Regulation	O
of	O
inosine-5'-monophosphate	B-protein
dehydrogenase	I-protein
type	I-protein
II	I-protein
gene	O
expression	O
in	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Role	O
for	O
a	O
novel	O
5	B-DNA
'	I-DNA
palindromic	I-DNA
octamer	I-DNA
sequence	I-DNA
.	O

Expression	O
of	O
the	O
gene	O
encoding	O
human	B-protein
inosine-	I-protein
5'-monophosphate	I-protein
dehydrogenase	I-protein
(	I-protein
IMPDH	I-protein
)	I-protein
type	I-protein
II	I-protein
,	O
an	O
enzyme	B-protein
catalyzing	O
the	O
rate-limiting	O
step	O
in	O
the	O
generation	O
of	O
guanine	O
nucleotides	O
,	O
is	O
increased	O
more	O
than	O
10-fold	O
in	O
activated	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
and	O
is	O
required	O
for	O
T	O
cell	O
activation	O
.	O

We	O
have	O
examined	O
the	O
5'-regulatory	B-DNA
sequences	I-DNA
that	O
are	O
important	O
for	O
the	O
transcriptional	O
regulation	O
of	O
this	O
gene	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

DNase	B-protein
I	I-protein
mapping	O
of	O
genomic	B-DNA
DNA	I-DNA
identified	O
a	O
hypersensitive	B-DNA
element	I-DNA
near	O
the	O
transcription	B-DNA
initiation	I-DNA
site	I-DNA
.	O

Fine	O
mapping	O
by	O
in	O
vivo	O
footprinting	O
demonstrated	O
five	O
transcription	O
factor	O
binding	O
sites	O
that	O
are	O
occupied	O
in	O
both	O
resting	O
and	O
activated	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
;	O
these	O
are	O
tandem	B-DNA
CRE	I-DNA
motifs	I-DNA
,	O
a	O
Sp1	B-DNA
site	I-DNA
,	O
an	O
overlapping	O
Egr-1/Sp1	B-DNA
site	I-DNA
,	O
and	O
a	O
novel	O
palindromic	B-DNA
octamer	I-DNA
sequence	I-DNA
(	O
POS	B-DNA
)	O
.	O

The	O
tandem	O
CRE	B-DNA
and	I-DNA
POS	I-DNA
sites	I-DNA
are	O
of	O
major	O
functional	O
importance	O
as	O
judged	O
by	O
mutational	O
and	O
electrophoretic	O
mobility	O
shift	O
analyses	O
.	O

These	O
data	O
provide	O
evidence	O
that	O
expression	O
of	O
the	O
human	B-DNA
IMPDH	I-DNA
type	I-DNA
II	I-DNA
gene	I-DNA
is	O
predominantly	O
regulated	O
by	O
the	O
nuclear	B-protein
factors	I-protein
ATF-2	B-protein
and	O
an	O
as	O
yet	O
unidentified	O
POS-binding	B-protein
protein	I-protein
.	O

Additional	O
major	O
protein-DNA	O
interactions	O
do	O
not	O
occur	O
within	O
the	O
promoter	O
region	O
after	O
T	O
lymphocyte	O
activation	O
,	O
indicating	O
a	O
requirement	O
for	O
additional	O
protein-protein	O
interactions	O
and/or	O
post-translational	O
modifications	O
of	O
pre-bound	B-protein
transcription	I-protein
factors	I-protein
to	O
account	O
for	O
the	O
observed	O
increase	O
in	O
IMPDH	O
type	O
II	O
gene	O
expression	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

36	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
5	NULL
,	NULL
pp	NULL
.	NULL

22913-22923	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Regulation	NULL
of	NULL
Inosine-5'-monophosphate	NULL
Dehydrogenase	NULL
Type	NULL
II	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
T	NULL
Cells	NULL
ROLE	NULL
FOR	NULL
A	NULL
NOVEL	NULL
5'°	NULL
PALINDROMIC	NULL
OCTAMER	NULL
SEQUENCE*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
February	NULL
18	NULL
,	NULL
1997	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
June	NULL
18	NULL
,	NULL
1997	NULL
)	NULL
Albert	NULL
G.	NULL
Zimmermann	NULL
}	NULL
,	NULL
Kenneth	NULL
L.	NULL
Wright§1	NULL
,	NULL
Jenny	NULL
P.-Y	NULL
.	NULL

Ting§1	NULL
,	NULL
and	NULL
Beverly	NULL
S.	NULL
Mitchell	NULL
#	NULL
1	NULL
]	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
{	NULL
Pharmacology	NULL
,	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
and	NULL
\|Internal	NULL
Medicine	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
and	NULL
the	NULL
Lineberger	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
North	NULL
Carolina	NULL
27599	NULL
Expression	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
human	NULL
inosine-	NULL
5'-monophosphate	NULL
dehydrogenase	NULL
(	NULL
IMPDH	NULL
)	NULL
type	NULL
II	NULL
,	NULL
an	NULL
enzyme	NULL
catalyzing	NULL
the	NULL
rate-limiting	NULL
step	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
guanine	NULL
nucleotides	NULL
,	NULL
is	NULL
increased	NULL
more	NULL
than	NULL
10-fold	NULL
in	NULL
activated	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
and	NULL
is	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
the	NULL
5-regulatory	NULL
sequences	NULL
that	NULL
are	NULL
important	NULL
for	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

DNase	NULL
I	NULL
mapping	NULL
of	NULL
genomic	NULL
DNA	NULL
identified	NULL
a	NULL
hypersensitive	NULL
element	NULL
near	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

Fine	NULL
mapping	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
demonstrated	NULL
five	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
that	NULL
are	NULL
occupied	NULL
in	NULL
both	NULL
resting	NULL
and	NULL
activated	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
;	NULL
these	NULL
are	NULL
tandem	NULL
CRE	NULL
motifs	NULL
,	NULL
a	NULL
Spl	NULL
site	NULL
,	NULL
an	NULL
overlapping	NULL
Egr-1/Spl	NULL
site	NULL
,	NULL
and	NULL
a	NULL
novel	NULL
palindromic	NULL
octamer	NULL
sequence	NULL
(	NULL
POS	NULL
)	NULL
.	NULL

The	NULL
tandem	NULL
CRE	NULL
and	NULL
POS	NULL
sites	NULL
are	NULL
of	NULL
major	NULL
functional	NULL
importance	NULL
as	NULL
judged	NULL
by	NULL
mutational	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
analyses	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
evidence	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
is	NULL
predominantly	NULL
regulated	NULL
by	NULL
the	NULL
nuclear	NULL
factors	NULL
ATF-2	NULL
and	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
POS-binding	NULL
protein	NULL
.	NULL

Additional	NULL
major	NULL
protein-DNA	NULL
interactions	NULL
do	NULL
not	NULL
occur	NULL
within	NULL
the	NULL
promoter	NULL
region	NULL
after	NULL
T	NULL
lymphocyte	NULL
activation	NULL
,	NULL
indicating	NULL
a	NULL
requirement	NULL
for	NULL
additional	NULL
protein-protein	NULL
interactions	NULL
and/or	NULL
post-translational	NULL
modifications	NULL
of	NULL
pre-bound	NULL
transcription	NULL
factors	NULL
to	NULL
account	NULL
for	NULL
the	NULL
observed	NULL
increase	NULL
in	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
expression	NULL
.	NULL

Cellular	NULL
inosine-5'-monophosphate	NULL
dehydrogenase	NULL
(	NULL
IM-PDH	NULL
,	NULL
EC	NULL
1.1.1.205	NULL
)	NULL
enzymatic	NULL
activity	NULL
is	NULL
the	NULL
result	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
two	NULL
independent	NULL
genes	NULL
,	NULL
IMPDH	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
,	NULL
that	NULL
encode	NULL
proteins	NULL
with	NULL
identical	NULL
catalytic	NULL
activities	NULL
(	NULL
1-5	NULL
)	NULL
.	NULL

IMPDH	NULL
catalyzes	NULL
the	NULL
NAD-dependent	NULL
oxidation	NULL
of	NULL
inosine	NULL
5	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
CA64192	NULL
and	NULL
CAS4085	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
``	NULL
/EBI	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
L39210	NULL
.	NULL

**To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
1106	NULL
FLOB	NULL
CB	NULL
7865	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
NC	NULL
27599-7865	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
919-966-4431	NULL
;	NULL
Fax	NULL
:	NULL
919-966-5640	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IMPDH	NULL
,	NULL
inosine-5'-monophosphate	NULL
de-hydrogenase	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
anal-ysis	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
CRE	NULL
,	NULL
cAMP	NULL
response	NULL
element	NULL
;	NULL
CREB	NULL
,	NULL
CRE	NULL
binding	NULL
protein	NULL
;	NULL
CREM	NULL
,	NULL
CRE	NULL
modulator	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
IL-2	NULL
,	NULL
interleukin-2	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
(	NULL
s	NULL
)	NULL
;	NULL
MRC	NULL
,	NULL
molecular	NULL
research	NULL
center	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
PMSF	NULL
,	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
;	NULL
POS	NULL
,	NULL
palindromic	NULL
octamer	NULL
sequence	NULL
;	NULL
RPMI	NULL
,	NULL
Roswell	NULL
Park	NULL
Memorial	NULL
Institute	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
monophosphate	NULL
to	NULL
xanthosine	NULL
5'-monophosphate	NULL
in	NULL
the	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
guanine	NULL
deoxy-	NULL
and	NULL
ribonucleotides	NULL
required	NULL
for	NULL
DNA	NULL
and	NULL
RNA	NULL
biosynthesis	NULL
,	NULL
respectively	NULL
.	NULL

Increased	NULL
IMPDH	NULL
activity	NULL
has	NULL
been	NULL
correlated	NULL
with	NULL
both	NULL
cellular	NULL
proliferation	NULL
and	NULL
malignant	NULL
transformation	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

The	NULL
IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
transcript	NULL
is	NULL
the	NULL
predominant	NULL
of	NULL
the	NULL
two	NULL
species	NULL
in	NULL
most	NULL
normal	NULL
cells	NULL
and	NULL
tissues	NULL
and	NULL
is	NULL
expressed	NULL
at	NULL
significantly	NULL
increased	NULL
levels	NULL
in	NULL
replicating	NULL
and	NULL
neoplastic	NULL
cells	NULL
and	NULL
upon	NULL
T	NULL
lymphocyte	NULL
activation	NULL
(	NULL
8-11	NULL
)	NULL
.	NULL

The	NULL
pivotal	NULL
role	NULL
that	NULL
this	NULL
increase	NULL
in	NULL
enzymatic	NULL
activity	NULL
and	NULL
concomitant	NULL
increase	NULL
in	NULL
guanine	NULL
nucleotide	NULL
biosynthesis	NULL
plays	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
is	NULL
illustrated	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
selective	NULL
IMPDH	NULL
inhibitors	NULL
,	NULL
such	NULL
as	NULL
mycophenolic	NULL
acid	NULL
and	NULL
mizoribine	NULL
,	NULL
to	NULL
abrogate	NULL
T	NULL
lymphocyte	NULL
responses	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

These	NULL
agents	NULL
also	NULL
induce	NULL
cell	NULL
differentiation	NULL
in	NULL
a	NULL
number	NULL
of	NULL
cultured	NULL
leukemic	NULL
cell	NULL
lines	NULL
(	NULL
15-18	NULL
)	NULL
and	NULL
in	NULL
primary	NULL
leukemic	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
blast	NULL
crisis	NULL
of	NULL
chronic	NULL
myelocytic	NULL
leukemia	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Such	NULL
inhibitors	NULL
are	NULL
in	NULL
current	NULL
clinical	NULL
use	NULL
as	NULL
immunosuppressive	NULL
drugs	NULL
in	NULL
the	NULL
prevention	NULL
of	NULL
allograft	NULL
rejection	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
human	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
located	NULL
on	NULL
chromosome	NULL
3p21.2	NULL
-	NULL
24.2	NULL
(	NULL
8	NULL
)	NULL
is	NULL
approximately	NULL
5.8	NULL
kb	NULL
in	NULL
length	NULL
and	NULL
consists	NULL
of	NULL
14	NULL
exons	NULL
varying	NULL
in	NULL
size	NULL
from	NULL
49	NULL
to	NULL
207	NULL
bp	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
initiation	NULL
site	NULL
was	NULL
located	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
and	NULL
RNase	NULL
protection	NULL
to	NULL
a	NULL
position	NULL
50	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
translation	NULL
initiation	NULL
codon	NULL
.	NULL

The	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
type	NULL
II	NULL
gene	NULL
previously	NULL
identified	NULL
as	NULL
containing	NULL
promoter	NULL
activity	NULL
consists	NULL
of	NULL
463	NULL
base	NULL
pairs	NULL
upstream	NULL
of	NULL
and	NULL
including	NULL
the	NULL
translation	NULL
initiation	NULL
site	NULL
.	NULL

Transfection	NULL
of	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
gene	NULL
construct	NULL
containing	NULL
this	NULL
DNA	NULL
sequence	NULL
into	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
expression	NULL
over	NULL
base	NULL
line	NULL
after	NULL
activation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
phorbol	NULL
ester	NULL
and	NULL
ionomycin	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
contains	NULL
the	NULL
regulatory	NULL
elements	NULL
necessary	NULL
for	NULL
the	NULL
activation	NULL
associated	NULL
increase	NULL
in	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
vitro	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
using	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
identified	NULL
four	NULL
protected	NULL
regions	NULL
in	NULL
the	NULL
promoter	NULL
that	NULL
coincided	NULL
with	NULL
consensus	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
including	NULL
AP2	NULL
,	NULL
tandem	NULL
CREs	NULL
,	NULL
an	NULL
overlapping	NULL
Egr-l/Spl	NULL
site	NULL
,	NULL
and	NULL
an	NULL
Nm23	NULL
motif	NULL
,	NULL
but	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
these	NULL
sites	NULL
remained	NULL
a	NULL
subject	NULL
of	NULL
speculation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
important	NULL
role	NULL
of	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
expression	NULL
in	NULL
both	NULL
T	NULL
lymphocyte	NULL
activation	NULL
and	NULL
neoplasia	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
molecular	NULL
mechanisms	NULL
governing	NULL
the	NULL
regulation	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
the	NULL
most	NULL
physiologically	NULL
relevant	NULL
system	NULL
,	NULL
human	NULL
primary	NULL
T	NULL
lymphocytes	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
specific	NULL
elements	NULL
required	NULL
for	NULL
differential	NULL
expression	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
,	NULL
we	NULL
have	NULL
asked	NULL
whether	NULL
differential	NULL
occupancy	NULL
of	NULL
specific	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
occurs	NULL
in	NULL
vivo	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
T	NULL
lymphocyte	NULL
activation	NULL
and	NULL
have	NULL
further	NULL
examined	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
these	NULL
sites	NULL
.	NULL

22913	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
22914	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Isolation	NULL
of	NULL
Peripheral	NULL
Blood	NULL
T	NULL
Lymphocytes-Buffy	NULL
coats	NULL
from	NULL
normal	NULL
donors	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Red	NULL
Cross	NULL
(	NULL
Charlotte	NULL
,	NULL
NC	NULL
)	NULL
,	NULL
and	NULL
the	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
using	NULL
Histopaque-1077	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Cells	NULL
at	NULL
the	NULL
interface	NULL
were	NULL
removed	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
(	NULL
850	NULL
x	NULL
g	NULL
,	NULL
87°C	NULL
)	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
Laboratories	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
depleted	NULL
by	NULL
adherence	NULL
and	NULL
B	NULL
lymphocytes	NULL
by	NULL
maintaining	NULL
cells	NULL
in	NULL
culture	NULL
for	NULL
3	NULL
days	NULL
prior	NULL
to	NULL
stimulation	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
the	NULL
isolated	NULL
T	NULL
lymphocytes	NULL
with	NULL
an	NULL
anti-CD2*	NULL
marker	NULL
revealed	NULL
a	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
enrichment	NULL
of	NULL
CD2*	NULL
T	NULL
cells	NULL
.	NULL

Cellular	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
into	NULL
DNA	NULL
from	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
was	NULL
determined	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
proliferative	NULL
activity	NULL
.	NULL

mRNA	NULL
Stability-Peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
(	NULL
10	NULL
``	NULL
cells/sample	NULL
)	NULL
from	NULL
a	NULL
single	NULL
donor	NULL
were	NULL
stimulated	NULL
consecutively	NULL
with	NULL
1	NULL
ug/ml	NULL
PHA	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
10	NULL
units/ml	NULL
IL-2	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
48	NULL
,	NULL
24	NULL
,	NULL
8	NULL
,	NULL
and	NULL
0	NULL
h.	NULL
At	NULL
time	NULL
0	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
5	NULL
ug/ml	NULL
actinomycin	NULL
D	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
0	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
h.	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
with	NULL
Tri-Reagent	NULL
(	NULL
MRC	NULL
,	NULL
Cincinnati	NULL
,	NULL
OH	NULL
)	NULL
,	NULL
dissolved	NULL
in	NULL
Formazol	NULL
(	NULL
MRC	NULL
)	NULL
,	NULL
and	NULL
5	NULL
pg	NULL
analyzed	NULL
on	NULL
denaturing	NULL
formaldehyde-agarose	NULL
gels	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
ZetaProbe	NULL
GT	NULL
membranes	NULL
(	NULL
Bio-Rad	NULL
)	NULL
using	NULL
Northern	NULL
transfer	NULL
solution	NULL
(	NULL
MRC	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
prehybridized	NULL
and	NULL
hybridized	NULL
according	NULL
to	NULL
and	NULL
using	NULL
the	NULL
high	NULL
efficiency	NULL
hybridization	NULL
system	NULL
(	NULL
MRC	NULL
)	NULL
and	NULL
sequentially	NULL
probed	NULL
with	NULL
random-primed	NULL
[	NULL
a-	NULL
``	NULL
°P	NULL
]	NULL
dCTP-labeled	NULL
full-length	NULL
IMPDH	NULL
type	NULL
II	NULL
cDNA	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
F.	NULL
Collart	NULL
,	NULL
Argonne	NULL
National	NULL
Laboratory	NULL
,	NULL
Argonne	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
a	NULL
[	NULL
y-*	NULL
``	NULL
PIATP	NULL
end-labeled	NULL
human	NULL
28	NULL
S	NULL
rRNA-specific	NULL
oligonucleotide	NULL
(	NULL
5'-AAAACGATCAGAGTAGTGGTATT-TCACCG-3	NULL
'	NULL
)	NULL
(	NULL
CLONTECH	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

mRNA	NULL
levels	NULL
were	NULL
quantitated	NULL
with	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
after	NULL
a	NULL
3-day	NULL
exposure	NULL
for	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
probe	NULL
and	NULL
a	NULL
4.5-h	NULL
exposure	NULL
for	NULL
the	NULL
28	NULL
S	NULL
rRNA	NULL
probe	NULL
.	NULL

IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
levels	NULL
were	NULL
normalized	NULL
for	NULL
28	NULL
S	NULL
rRNA	NULL
loading	NULL
,	NULL
and	NULL
the	NULL
values	NULL
were	NULL
plotted	NULL
on	NULL
a	NULL
logarithmic	NULL
scale	NULL
.	NULL

DNase	NULL
I-hypersensitive	NULL
Site	NULL
Analysis-The	NULL
locations	NULL
of	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
were	NULL
mapped	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Wu	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
nuclei	NULL
from	NULL
10°	NULL
Jurkat	NULL
T	NULL
E6-1	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
were	NULL
swollen	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
by	NULL
incubation	NULL
in	NULL
50	NULL
ml	NULL
of	NULL
hypotonic	NULL
reticulocyte	NULL
standard	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
10	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
)	NULL
,	NULL
isolated	NULL
by	NULL
centrifugation	NULL
(	NULL
500	NULL
%	NULL
g	NULL
,	NULL
4	NULL
°C	NULL
,	NULL
5	NULL
min	NULL
)	NULL
,	NULL
and	NULL
subsequently	NULL
lysed	NULL
(	NULL
4	NULL
°C	NULL
,	NULL
5	NULL
min	NULL
)	NULL
in	NULL
25	NULL
ml	NULL
of	NULL
reticulocyte	NULL
standard	NULL
buffer	NULL
containing	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
isolated	NULL
by	NULL
centrifugation	NULL
(	NULL
500	NULL
X	NULL
g	NULL
,	NULL
4	NULL
°C	NULL
,	NULL
5	NULL
min	NULL
)	NULL
,	NULL
resuspended	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
DNase	NULL
I	NULL
digestion	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
CaCl	NULL
,	NULL
)	NULL
,	NULL
and	NULL
digested	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
DNase	NULL
I	NULL
(	NULL
0	NULL
,	NULL
0.05	NULL
,	NULL
0.1	NULL
,	NULL
0.25	NULL
,	NULL
0.5	NULL
,	NULL
0.75	NULL
,	NULL
1	NULL
,	NULL
and	NULL
2	NULL
pg/ml	NULL
)	NULL
(	NULL
Worthington	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
freshly	NULL
prepared	NULL
proteinase	NULL
K	NULL
(	NULL
10	NULL
mg/m	NULL
!	NULL
)	NULL

(	NULL
Sigma	NULL
)	NULL
in	NULL
stop	NULL
solution	NULL
(	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
600	NULL
my	NULL
NaCl	NULL
,	NULL
5	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
)	NULL
.	NULL

Following	NULL
overnight	NULL
incubation	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
extracted	NULL
twice	NULL
with	NULL
phenol/chloroform	NULL
,	NULL
once	NULL
with	NULL
chloroform	NULL
and	NULL
subsequently	NULL
precipitated	NULL
with	NULL
isopropyl	NULL
alcohol	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2.5	NULL
M	NULL
NH	NULL
,	NULL
OAc	NULL
.	NULL

The	NULL
DNA	NULL
(	NULL
15	NULL
pug	NULL
)	NULL
was	NULL
digested	NULL
overnight	NULL
with	NULL
Sacl	NULL
and	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
denatured	NULL
in	NULL
0.5	NULL
M	NULL
NaOH	NULL
for	NULL
1	NULL
h	NULL
,	NULL
neutralized	NULL
in	NULL
1	NULL
M	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
1.5	NULL
M	NULL
NaCl	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
transferred	NULL
overnight	NULL
onto	NULL
ZetaProbe	NULL
GT	NULL
membrane	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
prehybridized	NULL
(	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
0.12	NULL
M	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
0.25	NULL
M	NULL
NaCl	NULL
,	NULL
7	NULL
%	NULL
SDS	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
42	NULL
°C	NULL
and	NULL
hybridized	NULL
overnight	NULL
in	NULL
high	NULL
efficiency	NULL
hybridization	NULL
system	NULL
(	NULL
MRC	NULL
)	NULL
with	NULL
[	NULL
y-	NULL
``	NULL
°PJATP	NULL
end-labeled	NULL
probes	NULL
obtained	NULL
by	NULL
PCR	NULL
of	NULL
exon	NULL
5	NULL
(	NULL
forward	NULL
primer	NULL
,	NULL
5'-TTCATCACAGACCCTGTGGTCCTC-3	NULL
'	NULL
;	NULL
reverse	NULL
primer	NULL
,	NULL
5'-CCAAGAAACAGTCATGTTCCTCCT-3	NULL
'	NULL
)	NULL
and	NULL
exons	NULL
6	NULL
and	NULL
7	NULL
(	NULL
forward	NULL
primer	NULL
,	NULL
5'-AAGACTTGGTGGTAGCCCCTGC-3	NULL
'	NULL
;	NULL
reverse	NULL
primer	NULL
,	NULL
5'-ACTTGTCATCCTCATGAGTGCC-3	NULL
'	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
autora-diographed	NULL
for	NULL
4	NULL
and	NULL
2	NULL
days	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
Vivo	NULL
Footprinting-In	NULL
vivo	NULL
methylation	NULL
and	NULL
isolation	NULL
of	NULL
DNA	NULL
from	NULL
T	NULL
lymphocytes	NULL
and	NULL
Jurkat	NULL
T	NULL
E6-1	NULL
cells	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PHA-L	NULL
(	NULL
6	NULL
ug/m	NULL
!	NULL
)	NULL

and	NULL
IL-2	NULL
(	NULL
10	NULL
units/ml	NULL
)	NULL
for	NULL
24	NULL
,	NULL
48	NULL
,	NULL
and	NULL
72	NULL
h	NULL
,	NULL
respectively	NULL
.	NULL

Jurkat	NULL
E6-1	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
!	NULL
)	NULL

for	NULL
3	NULL
h.	NULL
IL-2	NULL
receptor	NULL
expression	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
was	NULL
determined	NULL
by	NULL
flow	NULL
cytom-etry	NULL
using	NULL
the	NULL
CD25	NULL
antibody	NULL
M-A251	NULL
(	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
10°	NULL
)	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
,	NULL
resuspended	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
,	NULL
and	NULL
methylated	NULL
using	NULL
1	NULL
ul/ml	NULL
dimethyl	NULL
sulfate	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
ice-cold	NULL
PBS	NULL
containing	NULL
60	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
(	NULL
900	NULL
X	NULL
g	NULL
,	NULL
4	NULL
°C	NULL
,	NULL
2	NULL
min	NULL
)	NULL
,	NULL
washed	NULL
in	NULL
PBS/Tris	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IMPDH	NULL
Type	NULL
II	NULL
lysis	NULL
buffer	NULL
(	NULL
60	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
100	NULL
my	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
500	NULL
ug/ml	NULL
proteinase	NULL
K	NULL
)	NULL
for	NULL
4	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Genomic	NULL
DNA	NULL
was	NULL
extracted	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
phenol	NULL
followed	NULL
by	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
chloroform	NULL
:	NULL
isoamyl	NULL
alcohol	NULL
(	NULL
24:1	NULL
)	NULL
.	NULL

The	NULL
aqueous	NULL
phase	NULL
was	NULL
removed	NULL
and	NULL
extracted	NULL
with	NULL
chloroform	NULL
:	NULL
isoamyl	NULL
alcohol	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
spooled	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Vio	NULL
volume	NULL
of	NULL
3	NULL
M	NULL
NaOAc	NULL
and	NULL
2.5	NULL
volumes	NULL
of	NULL
ethanol	NULL
,	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
digested	NULL
with	NULL
100	NULL
units	NULL
of	NULL
HindIII	NULL
restriction	NULL
enzyme	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Digests	NULL
stored	NULL
overnight	NULL
(	NULL
4	NULL
°C	NULL
)	NULL
were	NULL
extracted	NULL
as	NULL
described	NULL
above	NULL
,	NULL
resuspended	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Control	NULL
DNA	NULL
was	NULL
methylated	NULL
in	NULL
vitro	NULL
with	NULL
1	NULL
ul	NULL
of	NULL
dimethyl	NULL
sulfate	NULL
for	NULL
15	NULL
s.	NULL
The	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
50	NULL
ul	NULL
of	NULL
1.5	NULL
M	NULL
NaOAc	NULL
,	NULL
pH	NULL
7	NULL
,	NULL
1	NULL
M	NULL
B-mercaptoethanol	NULL
,	NULL
100	NULL
ug/ml	NULL
tRNA	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
was	NULL
precipitated	NULL
with	NULL
750	NULL
ul	NULL
of	NULL
ethanol	NULL
.	NULL

Piperidine	NULL
diluted	NULL
1:10	NULL
(	NULL
200	NULL
pl	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
pellet	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
incubated	NULL
at	NULL
90	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
frozen	NULL
,	NULL
and	NULL
lyophilized	NULL
.	NULL

Two	NULL
additional	NULL
lyophilizations	NULL
were	NULL
performed	NULL
from	NULL
100	NULL
and	NULL
50	NULL
pl	NULL
of	NULL
distilled	NULL
H	NULL
,	NULL
O	NULL
volumes	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
was	NULL
diluted	NULL
to	NULL
1.5	NULL
pug/ul	NULL
in	NULL
distilled	NULL
H	NULL
,	NULL
O	NULL
.	NULL

The	NULL
ligation-mediated	NULL
PCR	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
with	NULL
modifications	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Two	NULL
primer	NULL
sets	NULL
were	NULL
used	NULL
to	NULL
encompass	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
5'-flanking	NULL
region	NULL
(	NULL
bp	NULL
-267	NULL
to	NULL
-14	NULL
)	NULL
upper	NULL
strand	NULL
:	NULL
P1	NULL
(	NULL
-838	NULL
)	NULL
,	NULL
5'-TTTTGGGGAGGAGCCCG-3	NULL
'	NULL
(	NULL
T	NULL
,	NULL
,	NULL
,	NULL
=	NULL
60°C	NULL
)	NULL
;	NULL
P2	NULL
(	NULL
-318	NULL
)	NULL
,	NULL
5-CGGCGGGACAGTAGAAGTAAACCCTTGC-3	NULL
'	NULL
(	NULL
T.	NULL
,	NULL
=	NULL
65	NULL
°C	NULL
)	NULL
;	NULL
P3	NULL
(	NULL
-818	NULL
)	NULL
,	NULL
5'-CGGCGGGACAGTAGAAGTAAACCCTT-GCCTG-3	NULL
'	NULL
(	NULL
T	NULL
,	NULL
,	NULL
=	NULL
67	NULL
°C	NULL
)	NULL
,	NULL
and	NULL
lower	NULL
strand	NULL
:	NULL
P1	NULL
(	NULL
83	NULL
)	NULL
,	NULL
5-TCTCCGCAGT-TGAAGAGC-3	NULL
'	NULL
(	NULL
T	NULL
,	NULL
,	NULL
=	NULL
58	NULL
°C	NULL
)	NULL
;	NULL
P2	NULL
(	NULL
29	NULL
)	NULL
,	NULL
5-GTGCCCCCACTAATCAGG-TAGTCGGC-3	NULL
'	NULL
(	NULL
T.	NULL
,	NULL
,	NULL
=	NULL
65	NULL
°C	NULL
)	NULL
;	NULL
P3	NULL
(	NULL
29	NULL
)	NULL
,	NULL
5-GTGCCCCCACTAATCAGGT-AGTCGGCCATG-3	NULL
'	NULL
(	NULL
T.	NULL
,	NULL
,	NULL
=	NULL
67	NULL
°C	NULL
)	NULL
.	NULL

Transient	NULL
Transfections-Chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
constructs	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
10	NULL
``	NULL
exponentially	NULL
growing	NULL
Jurkat	NULL
T	NULL
E6-1	NULL
cells	NULL
.	NULL

Promoter-deletion	NULL
CAT	NULL
constructs	NULL
were	NULL
transfected	NULL
in	NULL
equimolar	NULL
ratios	NULL
adjusted	NULL
for	NULL
promoter	NULL
insert	NULL
size	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
Laboratories	NULL
)	NULL
and	NULL
cultured	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

Electroporations	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RPMI	NULL
1640	NULL
lacking	NULL
Ca**	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
with	NULL
settings	NULL
at	NULL
250	NULL
V/960	NULL
microfarads	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
,	NULL
harvested	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
150	NULL
ul	NULL
of	NULL
0.25	NULL
M	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
and	NULL
extracted	NULL
with	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
.	NULL

Aliquots	NULL
were	NULL
heated	NULL
to	NULL
60	NULL
°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
centrifuged	NULL
at	NULL
16,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
assayed	NULL
with	NULL
0.1	NULL
Ci	NULL
of	NULL
[	NULL
'*C	NULL
)	NULL
chloramphenicol	NULL
and	NULL
25	NULL
ug	NULL
of	NULL
n-butyryl	NULL
coenzyme	NULL
A	NULL
for	NULL
2	NULL
h	NULL
,	NULL
extracted	NULL
with	NULL
xylenes	NULL
according	NULL
to	NULL
the	NULL
Promega	NULL
CAT	NULL
Enzyme	NULL
Assay	NULL
System	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
with	NULL
the	NULL
Micro	NULL
BCA	NULL
Protein	NULL
Assay	NULL
Reagent	NULL
Kit	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

Nuclear	NULL
Extracts-Nuclear	NULL
extracts	NULL
from	NULL
control	NULL
and	NULL
PMA	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
-treated	NULL
Jurkat	NULL
T	NULL
E6-1	NULL
cells	NULL
and	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PHA-L	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
IL-2	NULL
(	NULL
10	NULL
units/ml	NULL
)	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
for	NULL
3	NULL
,	NULL
6	NULL
,	NULL
12	NULL
,	NULL
and	NULL
24	NULL
h	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
with	NULL
modifications	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
extraction	NULL
was	NULL
performed	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
50	NULL
ml	NULL
of	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
5	NULL
pellet	NULL
volumes	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.75	NULL
mM	NULL
spermidine	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
my	NULL
EGTA	NULL
,	NULL
1	NULL
mm	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
)	NULL
,	NULL
incubated	NULL
for	NULL
5	NULL
min	NULL
,	NULL
homogenized	NULL
with	NULL
a	NULL
B	NULL
pestle	NULL
in	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
,	NULL
and	NULL
centrifuged	NULL
at	NULL
30,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
s.	NULL
The	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
pellet	NULL
volume	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.75	NULL
mM	NULL
spermidine	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mm	NULL
PMSF	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
)	NULL
,	NULL
the	NULL
NaCl	NULL
concentration	NULL
adjusted	NULL
to	NULL
0.4	NULL
M	NULL
,	NULL
the	NULL
nuclei	NULL
agitated	NULL
for	NULL
20	NULL
min	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
extract	NULL
subsequently	NULL
obtained	NULL
by	NULL
pelleting	NULL
the	NULL
nuclei	NULL
at	NULL
30,000	NULL
x	NULL
g	NULL
for	NULL
60	NULL
min	NULL
.	NULL

Control	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
was	NULL
subsequently	NULL
dialyzed	NULL
2	NULL
X	NULL
90	NULL
min	NULL
in	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
12.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
100	NULL
mm	NULL
KCl	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
17	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
aliquoted	NULL
and	NULL
stored	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays-Wild-type	NULL
and	NULL
mutant	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
generated	NULL
by	NULL
annealing	NULL
complementary	NULL
single-stranded	NULL
oligonucleotides	NULL
and	NULL
either	NULL
labeled	NULL
by	NULL
fill-in	NULL
using	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
or	NULL
kinasing	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Labeled	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
purified	NULL
on	NULL
1	NULL
ml	NULL
of	NULL
Sephadex	NULL
G-50	NULL
(	NULL
Sigma	NULL
)	NULL
columns	NULL
.	NULL

The	NULL
flow-through	NULL
was	NULL
precipitated	NULL
with	NULL
Vio	NULL
volume	NULL
of	NULL
3	NULL
M	NULL
NaQOAc	NULL
and	NULL
3	NULL
volumes	NULL
of	NULL
ethanol	NULL
,	NULL
washed	NULL
with	NULL
95	NULL
%	NULL
ethanol	NULL
,	NULL
and	NULL
resuspended	NULL
at	NULL
20,000	NULL
epm/ul	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
unlabeled	NULL
wild-type	NULL
and	NULL
mutant	NULL
oligonucleotides	NULL
were	NULL
prepared	NULL
by	NULL
using	NULL
unlabeled	NULL
deoxynucleotides	NULL
for	NULL
fill-in	NULL
and	NULL
precipitated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

One	NULL
ul	NULL
of	NULL
probe	NULL
(	NULL
approximately	NULL
0.1	NULL
ng	NULL
of	NULL
DNA	NULL
)	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IMPDH	NULL
Type	NULL
II	NULL
22915	NULL
0	NULL
h	NULL
3h	NULL
24	NULL
h	NULL
48	NULL
h	NULL
Mitogen	NULL
stimulation	NULL
(	NULL
h	NULL
)	NULL
f	NULL
--	NULL
f	NULL
A-	NULL
[	NULL
--	NULL
A	NULL
``	NULL
2.4	NULL
am	NULL
28S	NULL
*	NULL
#	NULL
185	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
half-life	NULL
determinations	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

A	NULL
,	NULL
resting	NULL
(	NULL
0	NULL
h	NULL
)	NULL
and	NULL
activated	NULL
(	NULL
8	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
)	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
were	NULL
treated	NULL
with	NULL
5	NULL
ug/ml	NULL
actinomycin	NULL
D	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
intervals	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
,	NULL
5	NULL
ug	NULL
run	NULL
on	NULL
denaturing	NULL
gels	NULL
,	NULL
blotted	NULL
onto	NULL
nylon	NULL
membrane	NULL
,	NULL
and	NULL
sequentially	NULL
probed	NULL
with	NULL
IMPDH	NULL
type	NULL
II	NULL
cDNA	NULL
and	NULL
a	NULL
28	NULL
S	NULL
rRNA-specific	NULL
oligonucleotide	NULL
.	NULL

B	NULL
,	NULL
IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
and	NULL
28	NULL
S	NULL
rRNA	NULL
levels	NULL
were	NULL
quantitated	NULL
using	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
and	NULL
IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
expression	NULL
normalized	NULL
for	NULL
28	NULL
S	NULL
rRNA	NULL
expression	NULL
.	NULL

[	NULL
°H	NULL
]	NULL
Thymidine	NULL
uptake	NULL
was	NULL
increased	NULL
15-fold	NULL
in	NULL
the	NULL
activated	NULL
T	NULL
lymphocytes	NULL
after	NULL
48	NULL
h	NULL
of	NULL
stimulation	NULL
.	NULL

J	NULL
120	NULL
IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
(	NULL
%	NULL
control	NULL
)	NULL
'..	NULL
'	NULL
.	NULL

``	NULL
``	NULL
``	NULL
“	NULL
``	NULL
©	NULL
a	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
~~	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
Actinomycin	NULL
D	NULL
(	NULL
h	NULL
)	NULL
--	NULL
@	NULL
-	NULL
_	NULL
resting	NULL
--	NULL
O-	NULL
3h	NULL
--	NULL
®	NULL
--	NULL
-	NULL
24h	NULL
48	NULL
h	NULL
was	NULL
incubated	NULL
with	NULL
8	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
0.5	NULL
mm	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
preincu-bated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
competitor	NULL
or	NULL
30-60	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibodies	NULL
.	NULL

Probe	NULL
was	NULL
added	NULL
to	NULL
the	NULL
mixture	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
native	NULL
4	NULL
%	NULL
polyacrylamide	NULL
(	NULL
30:1	NULL
,	NULL
ac-rylamide	NULL
:	NULL
bisacrylamide	NULL
)	NULL
,	NULL
0.5	NULL
X	NULL
Tris/borate/EDTA	NULL
minigels	NULL
at	NULL
100	NULL
V	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
autoradiographed	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
analysis	NULL
(	NULL
EMSA	NULL
)	NULL
supershift	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
each	NULL
antibody	NULL
as	NULL
follows	NULL
:	NULL
the	NULL
ATF-1	NULL
antibody	NULL
(	NULL
sc-270X	NULL
)	NULL
that	NULL
cross-reacts	NULL
with	NULL
CREB-1	NULL
and	NULL
CREM-1	NULL
,	NULL
and	NULL
the	NULL
specific	NULL
antibodies	NULL
ATF-1	NULL
(	NULL
sc-241X	NULL
%	NULL
)	NULL
,	NULL
ATF-2	NULL
(	NULL
sc-187X	NULL
)	NULL
,	NULL
CREB-1	NULL
(	NULL
sc-186X	NULL
)	NULL
,	NULL
CREM-1	NULL
(	NULL
sc-440X	NULL
)	NULL
,	NULL
Sp1	NULL
(	NULL
sc-59X	NULL
%	NULL
)	NULL
,	NULL
and	NULL
Eigr-1	NULL
(	NULL
sc-110X	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Deletion	NULL
Constructs-Promoter	NULL
fragments	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
filled-in	NULL
HindIII	NULL
site	NULL
of	NULL
pCATBasic	NULL
unless	NULL
stated	NULL
otherwise	NULL
.	NULL

A	NULL
466-bp	NULL
construct	NULL
containing	NULL
the	NULL
5'-flanking	NULL
region	NULL
extending	NULL
from	NULL
an	NULL
EcoRI	NULL
to	NULL
an	NULL
Neo	NULL
!	NULL

site	NULL
at	NULL
the	NULL
ATG	NULL
initiation	NULL
codon	NULL
in	NULL
the	NULL
first	NULL
exon	NULL
(	NULL
bp	NULL
-468	NULL
to	NULL
+3	NULL
)	NULL
was	NULL
obtained	NULL
by	NULL
isolating	NULL
the	NULL
region	NULL
from	NULL
pGEMA466	NULL
(	NULL
21	NULL
)	NULL
using	NULL
the	NULL
multiple	NULL
cloning	NULL
region	NULL
(	NULL
MCR	NULL
)	NULL
HindIIlV/Xbal	NULL
sites	NULL
and	NULL
subcloning	NULL
the	NULL
fragment	NULL
into	NULL
the	NULL
identical	NULL
sites	NULL
of	NULL
Basic	NULL
.	NULL

To	NULL
remove	NULL
the	NULL
translation	NULL
initiation	NULL
codon	NULL
,	NULL
a	NULL
461-bp	NULL
promoter	NULL
fragment	NULL
was	NULL
released	NULL
by	NULL
a	NULL
HindIIW/Msel	NULL
digest	NULL
,	NULL
the	NULL
insert	NULL
HindIII	NULL
site	NULL
filled	NULL
in	NULL
,	NULL
and	NULL
the	NULL
fragment	NULL
subcloned	NULL
into	NULL
pCATBasic	NULL
in	NULL
the	NULL
5	NULL
-	NULL
>	NULL
3	NULL
'	NULL
orientation	NULL
(	NULL
pCATBasic461	NULL
)	NULL
.	NULL

A	NULL
pCATBasic1027	NULL
promoter	NULL
construct	NULL
was	NULL
obtained	NULL
by	NULL
cloning	NULL
a	NULL
1029-bp	NULL
Neo	NULL
!	NULL

5	NULL
fragment	NULL
containing	NULL
the	NULL
translation	NULL
initiation	NULL
site	NULL
into	NULL
pCATBasic	NULL
in	NULL
5	NULL
-	NULL
>	NULL
3	NULL
'	NULL
orientation	NULL
and	NULL
removing	NULL
the	NULL
translation	NULL
initiation	NULL
site	NULL
by	NULL
replacing	NULL
the	NULL
3	NULL
'	NULL
region	NULL
with	NULL
the	NULL
SphAI	NULL
fragment	NULL
(	NULL
bp	NULL
-199	NULL
to	NULL
MCR	NULL
)	NULL
obtained	NULL
from	NULL
pCATBasic461	NULL
.	NULL

The	NULL
SpAI	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
pCATBasic	NULL
MCR	NULL
SpAI	NULL
in	NULL
5	NULL
-	NULL
38	NULL
``	NULL
orientation	NULL
to	NULL
obtain	NULL
pCATBasic197	NULL
.	NULL

The	NULL
SpAI	NULL
fragment	NULL
was	NULL
digested	NULL
with	NULL
NiaIV	NULL
(	NULL
bp	NULL
-148	NULL
)	NULL
,	NULL
treated	NULL
with	NULL
mung	NULL
bean	NULL
nuclease	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
3	NULL
'	NULL
region	NULL
subcloned	NULL
into	NULL
pCATBasic	NULL
to	NULL
yield	NULL
the	NULL
5	NULL
-	NULL
>	NULL
3	NULL
'	NULL
construct	NULL
pCATBasicl41	NULL
.	NULL

The	NULL
constructs	NULL
were	NULL
se-quenced	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
transfected	NULL
DNA	NULL
was	NULL
normalized	NULL
for	NULL
promoter	NULL
insert	NULL
size	NULL
.	NULL

Site-directed	NULL
Mutagenesis-Transcription	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
were	NULL
mutagenized	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
.	NULL

Primary	NULL
and	NULL
secondary	NULL
PCR	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
time	NULL
after	NULL
Actinomycin	NULL
D	NULL
treatment	NULL
(	NULL
h	NULL
)	NULL
Pfu	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
template	NULL
for	NULL
the	NULL
site-directed	NULL
mutagenesis	NULL
consisted	NULL
of	NULL
the	NULL
4.8-kb	NULL
genomic	NULL
clone	NULL
contained	NULL
in	NULL
pGEM7Zf	NULL
(	NULL
+	NULL
)	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
22-bp	NULL
forward	NULL
primer	NULL
5-TGGGCTGACA-GACTTTGCTGAC-3	NULL
'	NULL
annealing	NULL
to	NULL
position	NULL
-716	NULL
to	NULL
-695	NULL
bp	NULL
and	NULL
the	NULL
26-bp	NULL
reverse	NULL
complementary	NULL
primer	NULL
5-GTTGAAGAGCTGCTGTGCT-GTGAGTC-3	NULL
'	NULL
annealing	NULL
to	NULL
position	NULL
+49	NULL
to	NULL
+75	NULL
bp	NULL
relative	NULL
to	NULL
the	NULL
translation	NULL
initiation	NULL
site	NULL
were	NULL
used	NULL
as	NULL
the	NULL
flanking	NULL
primers	NULL
for	NULL
the	NULL
PCR-mediated	NULL
mutagenesis	NULL
.	NULL

Sequences	NULL
of	NULL
oligonucleotides	NULL
used	NULL
for	NULL
the	NULL
mutagenesis	NULL
are	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
mutated	NULL
461-bp	NULL
promoter	NULL
fragments	NULL
were	NULL
released	NULL
with	NULL
an	NULL
EcoRUVMscl	NULL
digest	NULL
,	NULL
filled-in	NULL
with	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
,	NULL
gel-purified	NULL
,	NULL
subcloned	NULL
into	NULL
the	NULL
filled-in	NULL
HindIII	NULL
site	NULL
of	NULL
pCATBasic	NULL
,	NULL
and	NULL
sequenced	NULL
.	NULL

A	NULL
promoter	NULL
construct	NULL
containing	NULL
both	NULL
CRE	NULL
site	NULL
mutations	NULL
was	NULL
generated	NULL
and	NULL
assayed	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

This	NULL
double	NULL
mutation	NULL
resulted	NULL
in	NULL
a	NULL
single	NULL
cytosine-bp	NULL
deletion	NULL
in	NULL
the	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
site	NULL
.	NULL

RESULTS	NULL
IMPDH	NULL
Type	NULL
II	NULL
mRNA	NULL
Stability	NULL
in	NULL
Resting	NULL
and	NULL
Activated	NULL
T	NULL
Lymphocytes-To	NULL
determine	NULL
whether	NULL
differential	NULL
mRNA	NULL
stability	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
increase	NULL
in	NULL
IMPDH	NULL
type	NULL
II	NULL
expression	NULL
,	NULL
mRNA	NULL
levels	NULL
were	NULL
quantitated	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
following	NULL
actinomycin	NULL
D	NULL
treatment	NULL
.	NULL

IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
levels	NULL
increased	NULL
in	NULL
a	NULL
time-dependent	NULL
fashion	NULL
upon	NULL
T	NULL
lymphocyte	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Levels	NULL
increased	NULL
2-	NULL
,	NULL
19-	NULL
,	NULL
and	NULL
15-fold	NULL
over	NULL
those	NULL
in	NULL
unstimulated	NULL
T	NULL
lymphocytes	NULL
after	NULL
3	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
of	NULL
stimulation	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
time	NULL
0	NULL
h	NULL
)	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
decrease	NULL
in	NULL
IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
after	NULL
actinomycin	NULL
D	NULL
treatment	NULL
was	NULL
similar	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
with	NULL
£1	NULL
,	NULL
values	NULL
of	NULL
6	NULL
,	NULL
4.5	NULL
,	NULL
5	NULL
,	NULL
and	NULL
5	NULL
h	NULL
at	NULL
0	NULL
,	NULL
3	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
of	NULL
stimulation	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
an	NULL
increase	NULL
in	NULL
mRNA	NULL
stability	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
confirms	NULL
our	NULL
previous	NULL
studies	NULL
implicating	NULL
a	NULL
primary	NULL
role	NULL
for	NULL
transcriptional	NULL
regulation	NULL
in	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
a	NULL
separate	NULL
experiment	NULL
,	NULL
we	NULL
quantitated	NULL
the	NULL
increase	NULL
in	NULL
IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
in	NULL
isolated	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
22916	NULL
Hypersensitive	NULL
site	NULL
|	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IMPDH	NULL
Type	NULL
II	NULL
Hypersensitive	NULL
sites	NULL
II	NULL
and	NULL
III	NULL
1	NULL
234	NULL
5	NULL
6789	NULL
37°	NULL
kb	NULL
TA	NULL
»	NULL
6.1=	NULL
*~	NULL
..	NULL
'	NULL
.	NULL

‘	NULL
-.o-a	NULL
-	NULL
C	NULL
3	NULL
w	NULL
#	NULL
#	NULL
as	NULL
<	NULL
>	NULL
Site	NULL
I	NULL
5'-Frag	NULL
o	NULL
o	NULL
ug	NULL
ws	NULL
Weer	NULL
3-Frag	NULL
.	NULL

‘	NULL
«	NULL
Site	NULL
II	NULL
#	NULL
e	NULL
Site	NULL
III	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

DNase	NULL
I-hypersensitive	NULL
site	NULL
analyses	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
.	NULL

A	NULL
,	NULL
Sacl	NULL
restriction	NULL
map	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
with	NULL
the	NULL
14	NULL
exons	NULL
denoted	NULL
by	NULL
open	NULL
boxes	NULL
.	NULL

The	NULL
six	NULL
exons	NULL
of	NULL
a	NULL
downstream	NULL
gene	NULL
are	NULL
represented	NULL
by	NULL
shaded	NULL
boxes	NULL
and	NULL
the	NULL
upstream	NULL
gene	NULL
by	NULL
a	NULL
hatched	NULL
box	NULL
.	NULL

Nuclei	NULL
from	NULL
the	NULL
human	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
0	NULL
and	NULL
37	NULL
°C	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
DNase	NULL
I	NULL
(	NULL
indicated	NULL
by	NULL
the	NULL
wedges	NULL
)	NULL
prior	NULL
to	NULL
isolation	NULL
of	NULL
genomic	NULL
DNA	NULL
,	NULL
digestion	NULL
with	NULL
the	NULL
restriction	NULL
enzyme	NULL
Sacl	NULL
,	NULL
and	NULL
Southern	NULL
blot	NULL
analysis	NULL
with	NULL
an	NULL
exon	NULL
5	NULL
(	NULL
B	NULL
)	NULL
or	NULL
exon	NULL
6/7	NULL
(	NULL
C	NULL
)	NULL
probe	NULL
.	NULL

The	NULL
4.8-	NULL
and	NULL
6.4-kb	NULL
genomic	NULL
SacI	NULL
fragments	NULL
and	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
three	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
schema	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
.	NULL

Replicated	NULL
DNA	NULL
size	NULL
markers	NULL
are	NULL
shown	NULL
to	NULL
the	NULL
Zeft	NULL
of	NULL
B.	NULL
CD4	NULL
and	NULL
CD8	NULL
T	NULL
lymphocyte	NULL
subpopulations	NULL
.	NULL

IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
levels	NULL
increased	NULL
11-fold	NULL
in	NULL
CD4	NULL
and	NULL
5-fold	NULL
in	NULL
CD8	NULL
cells	NULL
after	NULL
24	NULL
h	NULL
,	NULL
indicating	NULL
up-regulation	NULL
of	NULL
gene	NULL
expression	NULL
on	NULL
activation	NULL
of	NULL
both	NULL
lymphocyte	NULL
populations	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Mapping	NULL
of	NULL
DNase	NULL
I-hypersensitive	NULL
Elements	NULL
at	NULL
the	NULL
IMPDH	NULL
Type	NULL
II	NULL
Locus-To	NULL
define	NULL
cis-acting	NULL
regulatory	NULL
regions	NULL
in	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
,	NULL
the	NULL
chromatin	NULL
structure	NULL
of	NULL
the	NULL
gene	NULL
and	NULL
surrounding	NULL
regions	NULL
encompassing	NULL
approximately	NULL
11	NULL
kb	NULL
were	NULL
mapped	NULL
for	NULL
sites	NULL
that	NULL
are	NULL
hypersensitive	NULL
to	NULL
digestion	NULL
with	NULL
DNase	NULL
I	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

An	NULL
exon	NULL
5	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
3	NULL
``	NULL
end	NULL
of	NULL
a	NULL
4.8-kb	NULL
SacI	NULL
genomic	NULL
fragment	NULL
revealed	NULL
a	NULL
DNase	NULL
I-hypersensitive	NULL
element	NULL
(	NULL
I	NULL
)	NULL
that	NULL
localizes	NULL
to	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
previously	NULL
demonstrated	NULL
to	NULL
contain	NULL
promoter	NULL
activity	NULL
and	NULL
a	NULL
cluster	NULL
of	NULL
potential	NULL
transcription	NULL
factor	NULL
binding	NULL
motifs	NULL
that	NULL
include	NULL
AP2	NULL
,	NULL
CRE	NULL
,	NULL
Egr-1	NULL
,	NULL
Nm23	NULL
,	NULL
and	NULL
Spl	NULL
(	NULL
21	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

An	NULL
exon	NULL
6	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
5	NULL
end	NULL
of	NULL
a	NULL
6.4-kb	NULL
Sacl	NULL
genomic	NULL
fragment	NULL
identified	NULL
a	NULL
region	NULL
containing	NULL
two	NULL
hypersensitive	NULL
elements	NULL
(	NULL
II	NULL
and	NULL
III	NULL
)	NULL
approximately	NULL
0.5	NULL
kb	NULL
apart	NULL
and	NULL
located	NULL
2.5	NULL
and	NULL
3.0	NULL
kb	NULL
3	NULL
'	NULL
to	NULL
the	NULL
end	NULL
of	NULL
the	NULL
coding	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Further	NULL
sequencing	NULL
of	NULL
this	NULL
region	NULL
demonstrated	NULL
sequence	NULL
identities	NULL
with	NULL
several	NULL
cDNA	NULL
sequences	NULL
(	NULL
WO1132	NULL
,	NULL
D61550	NULL
,	NULL
D81230	NULL
,	NULL
and	NULL
N27626	NULL
)	NULL
in	NULL
Gen-Bank	NULL
.	NULL

Alignment	NULL
of	NULL
these	NULL
overlapping	NULL
cDNA	NULL
fragments	NULL
with	NULL
the	NULL
region	NULL
3	NULL
'	NULL
to	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
identified	NULL
a	NULL
2-kb	NULL
gene	NULL
that	NULL
is	NULL
oriented	NULL
tail-to-tail	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
and	NULL
terminates	NULL
1	NULL
kb	NULL
3	NULL
'	NULL
to	NULL
it	NULL
.	NULL

This	NULL
gene	NULL
contains	NULL
6	NULL
exons	NULL
of	NULL
289	NULL
,	NULL
113	NULL
,	NULL
190	NULL
,	NULL
67	NULL
,	NULL
99	NULL
,	NULL
and	NULL
232	NULL
bp	NULL
with	NULL
corresponding	NULL
introns	NULL
of	NULL
80	NULL
,	NULL
120	NULL
,	NULL
161	NULL
,	NULL
107	NULL
,	NULL
and	NULL
79	NULL
bp	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
shaded	NULL
boxes	NULL
)	NULL
.	NULL

DNase	NULL
I-hypersensitive	NULL
sites	NULL
II	NULL
and	NULL
III	NULL
are	NULL
located	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
this	NULL
gene	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
its	NULL
regulation	NULL
rather	NULL
than	NULL
in	NULL
that	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
.	NULL

Additional	NULL
GenBank	NULL
cDNA	NULL
sequences	NULL
(	NULL
N51229	NULL
,	NULL
H56404	NULL
,	NULL
and	NULL
H80241	NULL
)	NULL
were	NULL
found	NULL
to	NULL
be	NULL
100	NULL
%	NULL
identical	NULL
to	NULL
a	NULL
713-bp	NULL
region	NULL
extending	NULL
5	NULL
from	NULL
bp	NULL
-307	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
(	NULL
21	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
hatched	NULL
box	NULL
)	NULL
.	NULL

Similar	NULL
sequences	NULL
were	NULL
found	NULL
at	NULL
the	NULL
same	NULL
location	NULL
upstream	NULL
of	NULL
the	NULL
mouse	NULL
IMPDH	NULL
type	NULL
II	NULL
coding	NULL
region	NULL
.	NULL

From	NULL
these	NULL
data	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
and	NULL
another	NULL
unidentified	NULL
gene	NULL
5	NULL
to	NULL
it	NULL
are	NULL
oriented	NULL
head-to-head	NULL
to	NULL
one	NULL
another	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
intergenic	NULL
region	NULL
could	NULL
serve	NULL
as	NULL
a	NULL
bidirectional	NULL
promoter	NULL
for	NULL
both	NULL
genes	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
previous	NULL
results	NULL
demonstrated	NULL
that	NULL
a	NULL
466-bp	NULL
IMPDH	NULL
type	NULL
II	NULL
promoter	NULL
CAT	NULL
construct	NULL
was	NULL
active	NULL
in	NULL
both	NULL
the	NULL
5	NULL
-	NULL
>	NULL
3	NULL
'	NULL
and	NULL
3	NULL
'	NULL
-	NULL
>	NULL
5	NULL
'	NULL
orienta-tions	NULL
,	NULL
with	NULL
7-fold	NULL
less	NULL
activity	NULL
with	NULL
the	NULL
latter	NULL
construct	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
and	NULL
function	NULL
of	NULL
the	NULL
proteins	NULL
encoded	NULL
by	NULL
the	NULL
two	NULL
genes	NULL
closely	NULL
flanking	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
are	NULL
currently	NULL
unknown	NULL
.	NULL

Delineation	NULL
of	NULL
a	NULL
Minimal	NULL
IMPDH	NULL
Type	NULL
II	NULL
Promoter-To	NULL
define	NULL
the	NULL
boundaries	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
and	NULL
the	NULL
relevance	NULL
of	NULL
the	NULL
specific	NULL
cis-acting	NULL
elements	NULL
that	NULL
were	NULL
previously	NULL
identified	NULL
by	NULL
in	NULL
vitro	NULL
footprinting	NULL
(	NULL
21	NULL
)	NULL
,	NULL
transient	NULL
transfection	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
promoter-deletion	NULL
CAT	NULL
reporter	NULL
constructs	NULL
using	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Constructs	NULL
containing	NULL
1027	NULL
,	NULL
461	NULL
,	NULL
and	NULL
197	NULL
bp	NULL
of	NULL
5	NULL
'	NULL
-flanking	NULL
sequence	NULL
terminating	NULL
2	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
translation	NULL
initiation	NULL
site	NULL
were	NULL
examined	NULL
for	NULL
promoter	NULL
activity	NULL
and	NULL
found	NULL
to	NULL
increase	NULL
CAT	NULL
activity	NULL
by	NULL
264	NULL
,	NULL
326	NULL
,	NULL
and	NULL
278-fold	NULL
over	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IMPDH	NULL
Type	NULL
II	NULL
22917	NULL
transcription	NULL
start	NULL
ATG	NULL
§	NULL
)	NULL
d9/1463	NULL
-	NULL
am	NULL
a	NULL
als	NULL
pCATBasic1027	NULL
L	NULL
‘	NULL
Qﬂf	NULL
‘	NULL
cé	NULL
”	NULL
r	NULL
a	NULL
pCATBasic461	NULL
-	NULL
_	NULL
_	NULL
_	NULL
J4§3	NULL
a	NULL
pCATBasic197	NULL
._	NULL
__	NULL
é.-______	NULL
--	NULL
--	NULL
--	NULL
-____	NULL
--	NULL
--	NULL
--	NULL
--	NULL
'1E	NULL
:	NULL
’	NULL
9	NULL
(	NULL
Sph	NULL
'	NULL
)	NULL
pCATBasic141	NULL
LLL	NULL
ll	NULL
é._______________________________:1	NULL
:	NULL
:	NULL
“	NULL
M_'é_	NULL
``	NULL
m	NULL
B	NULL
12000	NULL
10000	NULL
7	NULL
8000	NULL
7	NULL
6000	NULL
4000	NULL
7	NULL
CAT	NULL
activity	NULL
(	NULL
¢pm/mg/min	NULL
)	NULL
2000	NULL
7	NULL
KS	NULL
]	NULL
E	NULL
G	NULL
€	NULL
<	NULL
I	NULL
Q	NULL
O.	NULL
pCATBasic1027	NULL
pCATBasic461	NULL
pCATBasic197	NULL
pCATBasic141	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
's	NULL
5'-flanking	NULL
region	NULL
and	NULL
the	NULL
deletion	NULL
constructs	NULL
with	NULL
the	NULL
position	NULL
of	NULL
transcription	NULL
factor	NULL
binding	NULL
motifs	NULL
shown	NULL
relative	NULL
to	NULL
the	NULL
deleted	NULL
regions	NULL
and	NULL
the	NULL
transcription	NULL
and	NULL
translation	NULL
initiation	NULL
sites	NULL
.	NULL

B	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
activities	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
deletion	NULL
constructs	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
duplicate	NULL
determinations	NULL
in	NULL
a	NULL
single	NULL
experiment	NULL
.	NULL

Data	NULL
from	NULL
two	NULL
additional	NULL
experiments	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

pCATBasic	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
activities	NULL
among	NULL
these	NULL
constructs	NULL
in	NULL
three	NULL
experiments	NULL
were	NULL
not	NULL
significant	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
197-bp	NULL
5'-flanking	NULL
region	NULL
(	NULL
pCATBasic197	NULL
)	NULL
contains	NULL
the	NULL
elements	NULL
required	NULL
for	NULL
constitu-tive	NULL
IMPDH	NULL
type	NULL
II	NULL
promoter	NULL
activity	NULL
in	NULL
this	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

However	NULL
,	NULL
a	NULL
further	NULL
truncation	NULL
of	NULL
56	NULL
bp	NULL
(	NULL
pCATBasicl41	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
72	NULL
%	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
elements	NULL
in	NULL
this	NULL
region	NULL
including	NULL
the	NULL
overlapping	NULL
Egr-l/Spl	NULL
site	NULL
(	NULL
bp	NULL
-143	NULL
to	NULL
-199	NULL
)	NULL
contribute	NULL
significantly	NULL
to	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
pCATBasicl41l	NULL
construct	NULL
that	NULL
accounts	NULL
for	NULL
the	NULL
residual	NULL
28	NULL
%	NULL
of	NULL
promoter	NULL
activity	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
Spl	NULL
,	NULL
the	NULL
ATE/CREB	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
TATA-binding	NULL
protein	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
Vivo	NULL
Footprinting-To	NULL
clarify	NULL
the	NULL
in	NULL
vivo	NULL
significance	NULL
of	NULL
putative	NULL
regulatory	NULL
regions	NULL
in	NULL
the	NULL
promoter	NULL
,	NULL
we	NULL
performed	NULL
in	NULL
vivo	NULL
footprinting	NULL
experiments	NULL
on	NULL
DNA	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
and	NULL
control	NULL
and	NULL
PMA-treated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Two	NULL
primer	NULL
sets	NULL
were	NULL
used	NULL
to	NULL
visualize	NULL
the	NULL
regions	NULL
between	NULL
nucleotides	NULL
-267	NULL
and	NULL
-14	NULL
relative	NULL
to	NULL
the	NULL
ATG	NULL
translation	NULL
initiation	NULL
site	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
identifies	NULL
a	NULL
number	NULL
of	NULL
contact	NULL
regions	NULL
on	NULL
both	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
DNA	NULL
strands	NULL
of	NULL
this	NULL
region	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
plus	NULL
inset	NULL
and	NULL
B	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Alignment	NULL
of	NULL
these	NULL
protein-DNA	NULL
contact	NULL
sites	NULL
with	NULL
the	NULL
promoter	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
identified	NULL
clustering	NULL
at	NULL
several	NULL
putative	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
including	NULL
the	NULL
tandem	NULL
CRE	NULL
motifs	NULL
(	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
(	NULL
-88	NULL
to	NULL
-95	NULL
)	NULL
and	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
(	NULL
-114	NULL
to	NULL
-121	NULL
)	NULL
)	NULL
,	NULL
a	NULL
Spl	NULL
site	NULL
(	NULL
-133	NULL
to	NULL
-142	NULL
)	NULL
,	NULL
and	NULL
an	NULL
overlapping	NULL
Spl/Egr-1	NULL
site	NULL
(	NULL
-162	NULL
to	NULL
-172	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
protein-DNA	NULL
contacts	NULL
were	NULL
observed	NULL
at	NULL
a	NULL
site	NULL
we	NULL
have	NULL
termed	NULL
the	NULL
``	NULL
palindromic	NULL
octamer	NULL
sequence	NULL
``	NULL
or	NULL
POS	NULL
(	NULL
CGCATGCG	NULL
)	NULL
(	NULL
-193	NULL
to	NULL
-200	NULL
)	NULL
that	NULL
does	NULL
not	NULL
correspond	NULL
with	NULL
any	NULL
known	NULL
transcription	NULL
factor	NULL
binding	NULL
site	NULL
identified	NULL
in	NULL
the	NULL
Genetics	NULL
Computer	NULL
Group	NULL
transcription	NULL
factor	NULL
data	NULL
base	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

The	NULL
detected	NULL
binding	NULL
sites	NULL
were	NULL
similar	NULL
,	NULL
although	NULL
not	NULL
identical	NULL
,	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
and	NULL
control	NULL
and	NULL
PMA-treated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
regions	NULL
of	NULL
minor	NULL
change	NULL
in	NULL
protein-DNA	NULL
contacts	NULL
observed	NULL
upon	NULL
T	NULL
lymphocyte	NULL
activation	NULL
are	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
upper	NULL
DNA	NULL
strand	NULL
revealed	NULL
an	NULL
enhanced	NULL
cleavage	NULL
site	NULL
at	NULL
bp	NULL
-42	NULL
adjacent	NULL
to	NULL
a	NULL
consensus	NULL
AML1-binding	NULL
site	NULL
in	NULL
resting	NULL
T	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Extensions	NULL
of	NULL
the	NULL
footprints	NULL
at	NULL
the	NULL
POS	NULL
site	NULL
(	NULL
bp	NULL
-212	NULL
and	NULL
-215	NULL
)	NULL
and	NULL
TATA	NULL
box	NULL
(	NULL
bp	NULL
-83	NULL
)	NULL
were	NULL
noted	NULL
on	NULL
the	NULL
lower	NULL
strand	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
22918	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IMPDH	NULL
Type	NULL
II	NULL
A	NULL
-	NULL
_Jurkat	NULL
|	NULL
5	NULL
T	NULL
lymphocyte	NULL
s	NULL
;	NULL
B	NULL
;	NULL
Jurkat	NULL
i	NULL
T	NULL
lymphocyte	NULL
,	NULL
E735	NULL
£	NULL
&	NULL
IE	NULL
}	NULL
?	NULL

a	NULL
OZ	NULL
I	NULL
¥	NULL
é	NULL
?	NULL
)	NULL

£5	NULL
if	NULL
?	NULL

é	NULL
?	NULL
)	NULL

«	NULL
<	NULL
«	NULL
<	NULL
<	NULL
oris	NULL
<	NULL
_	NULL
&	NULL
§	NULL
o	NULL
&	NULL
&	NULL
q	NULL
@	NULL
@	NULL
its	NULL
]	NULL
:	NULL
fe-	NULL
tms	NULL
-	NULL
25	NULL
wa	NULL
yin	NULL
wee	NULL
w-	NULL
»	NULL
AML1	NULL
CEO	NULL
J	NULL
as	NULL
-	NULL
<	NULL
==	NULL
w-	NULL
m	NULL
seep	NULL
C	NULL
m	NULL
TATA	NULL
C	NULL
laa	NULL
Pos	NULL
_C	NULL
ye	NULL
|	NULL
==	NULL
ches	NULL
)	NULL
cms	NULL
Co	NULL
ea	NULL
<	NULL
--	NULL
Egr-1/	NULL
[	NULL
C	NULL
hs	NULL
i	NULL
-	NULL
#	NULL
-	NULL
#	NULL
e	NULL
Sp1	NULL
l	NULL
l	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
[	NULL
-	NULL
Win	NULL
ewaue	NULL
wan	NULL
aum	NULL
«	NULL
«	NULL
t=	NULL
geen	NULL
mnie	NULL
«	NULL
o=	NULL
«	NULL
aman	NULL
140	NULL
ts	NULL
_	NULL
-E	NULL
jaf	NULL
j=	NULL
Sp1	NULL
C	NULL
sue	NULL
whit	NULL
|-	NULL
Sp1	NULL
E	NULL
Wile	NULL
HHD	NULL
=	NULL
»	NULL
«	NULL
a-wasn	NULL
wass	NULL
wars	NULL
us	NULL
wiih	NULL
***	NULL
*~	NULL
(	NULL
_	NULL
,	NULL
F	NULL
THG	NULL
wo	NULL
cams	NULL
eee	NULL
=-	NULL
Tag	NULL
sis	NULL
S	NULL
L.	NULL
taa	NULL
tae	NULL
BS	NULL
week	NULL
me	NULL
mome	NULL
Ss	NULL
(	NULL
1-	NULL
co~	NULL
cao	NULL
©	NULL
7	NULL
was	NULL
wiz	NULL
,	NULL
wam	NULL
«	NULL
~	NULL
l	NULL
Spi	NULL
«	NULL
uous	NULL
cums	NULL
e	NULL
g	NULL
=	NULL
a	NULL
©	NULL
=-	NULL
e	NULL
``	NULL
~	NULL
(	NULL
d	NULL
pusimil	NULL
p	NULL
-ral	NULL
-	NULL
m	NULL
la-=	NULL
mas	NULL
me	NULL
=	NULL
==	NULL
-	NULL
b*	NULL
:	NULL
L_	NULL
_	NULL
e	NULL
=	NULL
TATA	NULL
[	NULL
cous	NULL
«	NULL
..	NULL
cake	NULL
cuss	NULL
o=	NULL
&	NULL
&	NULL
a	NULL
um	NULL
=	NULL
=	NULL
=~	NULL
i	NULL
as	NULL
#	NULL
HB	NULL
w	NULL
Wh	NULL
-	NULL
!	NULL

=	NULL
;	NULL
[	NULL
**	NULL
wee	NULL
Sese	NULL
to	NULL
£	NULL
%	NULL
a	NULL
a	NULL
s	NULL
ig	NULL
|-267	NULL
-300	NULL
AAACCCTTGCCTGTTAATTGAACTGGCCGAGGTCCTECGGGGAGTGTGGGGTEECACGTGAACTGCCAGCTCCTCAGTGACAACCCCACTATCTCCTATA	NULL
TTTGGGAACGGACAATTAACTTGACCGGCTCCAGGACGCCCCTCACACCCCACCCTGCACTTCACCGTCGAGGAGTCACTGTTCCGGTGATACACGATAT	NULL
TGTTTCTTCAGCGCCAGC	NULL
ACAAAGAAGTCGCGGTCCAR	NULL
CAGCGAGGCGGGTAGGTT	NULL
GTCGCTCCGCCCATCCA	NULL
CGTCGCGCGCAG	NULL
*	NULL
Pos	NULL
Egr-1/Sp1	NULL
Spi	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
transcription	NULL
start	NULL
Y	NULL
GGCTGGTTTATATTGGCGCGSCCCAGACGCCAGAGGTCTCTGC	NULL
GCCGACCAAATATAACCGCGCCGGGTCTGCCGTCTCCAGAGACG	NULL
GGAGACACGCGGCGETGTCCTETETTEGCCAT	NULL
CCTCTGTGCGCCGCCACAGGACACAACCGGTA	NULL
*	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
AML1	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
protein-DNA	NULL
interactions	NULL
in	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
promoter	NULL
by	NULL
ligation-mediated	NULL
PCR	NULL
.	NULL

In	NULL
vivo	NULL
footprint	NULL
analysis	NULL
of	NULL
the	NULL
upper	NULL
(	NULL
A	NULL
)	NULL
and	NULL
lower	NULL
(	NULL
B	NULL
)	NULL
strands	NULL
of	NULL
the	NULL
proximal	NULL
IMPDH	NULL
type	NULL
II	NULL
promoter	NULL
.	NULL

Control	NULL
DNA	NULL
was	NULL
methylated	NULL
in	NULL
vitro	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
DNA	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
Zanes	NULL
I	NULL
and	NULL
2	NULL
)	NULL
and	NULL
resting	NULL
and	NULL
activated	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
(	NULL
lanes	NULL
4-7	NULL
)	NULL
was	NULL
methylated	NULL
in	NULL
vivo	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Stimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
resulted	NULL
in	NULL
increases	NULL
in	NULL
uptake	NULL
of	NULL
3-	NULL
,	NULL
81-	NULL
,	NULL
192-fold	NULL
at	NULL
24	NULL
,	NULL
48	NULL
,	NULL
and	NULL
72	NULL
h	NULL
,	NULL
respectively	NULL
.	NULL

IL-2	NULL
receptor	NULL
expression	NULL
increased	NULL
from	NULL
16	NULL
%	NULL
in	NULL
resting	NULL
cells	NULL
to	NULL
89	NULL
,	NULL
95	NULL
,	NULL
and	NULL
98	NULL
%	NULL
in	NULL
the	NULL
24-	NULL
,	NULL
48-	NULL
,	NULL
and	NULL
72-h	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Flow	NULL
cytometric	NULL
mean	NULL
channel	NULL
fluorescence	NULL
increased	NULL
from	NULL
21	NULL
in	NULL
the	NULL
resting	NULL
T	NULL
lymphocytes	NULL
to	NULL
140	NULL
,	NULL
361	NULL
,	NULL
and	NULL
505	NULL
in	NULL
24-	NULL
,	NULL
48-	NULL
,	NULL
and	NULL
72-h	NULL
activated	NULL
T	NULL
lymphocytes	NULL
,	NULL
respectively	NULL
.	NULL

Open	NULL
arrows	NULL
indicate	NULL
protected	NULL
sites	NULL
and	NULL
solid	NULL
arrows	NULL
sites	NULL
of	NULL
enhanced	NULL
DNA	NULL
cleavage	NULL
with	NULL
shorter	NULL
arrows	NULL
indicating	NULL
reduced	NULL
protection	NULL
from	NULL
or	NULL
enhancement	NULL
of	NULL
DNA	NULL
cleavage	NULL
.	NULL

The	NULL
vertical	NULL
arrow	NULL
indicates	NULL
the	NULL
location	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

C	NULL
,	NULL
sequence	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
promoter	NULL
and	NULL
summary	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
contact	NULL
points	NULL
.	NULL

Transcription	NULL
factor	NULL
binding	NULL
sites	NULL
are	NULL
indicated	NULL
by	NULL
shaded	NULL
boxes	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
three	NULL
times	NULL
on	NULL
T	NULL
lymphocytes	NULL
and	NULL
twice	NULL
on	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

in	NULL
T	NULL
lymphocytes	NULL
treated	NULL
with	NULL
PHA	NULL
and	NULL
IL-2	NULL
for	NULL
24	NULL
,	NULL
48	NULL
,	NULL
and	NULL
_	NULL
lymphocytes	NULL
at	NULL
the	NULL
Egr-1/Spl	NULL
site	NULL
(	NULL
bp	NULL
-162	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
72	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
5-7	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
an	NULL
enhanced	NULL
cleavage	NULL
site	NULL
5-7	NULL
)	NULL
.	NULL

The	NULL
apparent	NULL
protection	NULL
observed	NULL
on	NULL
the	NULL
lower	NULL
DNA	NULL
was	NULL
observed	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
activated	NULL
T__	NULL
strand	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
Fig	NULL
.	NULL

4B	NULL
was	NULL
not	NULL
consistently	NULL
observed	NULL
in	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IMPDH	NULL
Type	NULL
II	NULL
22919	NULL
TaBLE	NULL
I	NULL
Sequences	NULL
of	NULL
oligonucleotides	NULL
used	NULL
for	NULL
site-directed	NULL
mutagenesis	NULL
and	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
Mutated	NULL
bases	NULL
are	NULL
shown	NULL
in	NULL
bold	NULL
,	NULL
and	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
are	NULL
underlined	NULL
.	NULL

The	NULL
sequences	NULL
represent	NULL
double-stranded	NULL
oligonucleotides	NULL
after	NULL
fill-in	NULL
with	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
or	NULL
kinasing	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

Wild-type	NULL
Mutant	NULL
POS	NULL
5'-TGTGCTATACGCATGCGCTGTTTCTTCAGC-3	NULL
'	NULL
Egr-1/Spl	NULL
5'-GCCAGCTCCGCCCCCceccecacceac-3	NULL
'	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
5'-ACTACGCCCToAceTcaAccetcaecec-3	NULL
``	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
5'-CGCAGCGCAGTGACGAAATCceccTcc-3	NULL
'	NULL
AML1L	NULL
5'-CCACTATGTGCTATACACATACACTGTTTCTTCAGCGCC-3	NULL
'	NULL
5'-CAGCGCCAGCTCCAACCCAACCGCAGCGAGGCG-3	NULL
'	NULL
5'-CACTACGCCCTGAATTCAGCGTCGCcoce-3	NULL
'	NULL
5'-CGCAGCGCAGTGAATAAATCGGCTGGTTTATATTGG-3	NULL
'	NULL
5'-GAGGTCTCTGCGGCGCAATCCTCGGAGACACGC-3	NULL
'	NULL
these	NULL
experiments	NULL
and	NULL
also	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
on	NULL
longer	NULL
gel	NULL
runs	NULL
of	NULL
the	NULL
upper	NULL
DNA	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Together	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
nuclear	NULL
proteins	NULL
are	NULL
pre-bound	NULL
at	NULL
the	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
,	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
,	NULL
Sp1	NULL
,	NULL
the	NULL
overlapping	NULL
Egr-1/Sp1	NULL
,	NULL
and	NULL
the	NULL
POS	NULL
sites	NULL
in	NULL
resting	NULL
T	NULL
lymphocytes	NULL
and	NULL
that	NULL
PHA	NULL
and	NULL
IL-2	NULL
stimu-lations	NULL
,	NULL
while	NULL
perhaps	NULL
modifying	NULL
these	NULL
proteins	NULL
or	NULL
causing	NULL
additional	NULL
protein-protein	NULL
interactions	NULL
,	NULL
do	NULL
not	NULL
result	NULL
in	NULL
major	NULL
additional	NULL
protein-DNA	NULL
interactions	NULL
.	NULL

Mutational	NULL
Analysis	NULL
of	NULL
Transcription	NULL
Factor	NULL
Binding	NULL
Sites-Site-directed	NULL
mutations	NULL
were	NULL
engineered	NULL
at	NULL
the	NULL
Eigr-1/Spl	NULL
,	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
,	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
AML1	NULL
sites	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
POS	NULL
site	NULL
in	NULL
the	NULL
pCATBasic461	NULL
construct	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
each	NULL
mutation	NULL
were	NULL
shown	NULL
not	NULL
to	NULL
compete	NULL
with	NULL
their	NULL
respective	NULL
wild-type	NULL
sequences	NULL
for	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
in	NULL
EMSA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
demonstrates	NULL
that	NULL
mutation	NULL
of	NULL
the	NULL
proximal	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
motif	NULL
(	NULL
located	NULL
between	NULL
bp	NULL
-88	NULL
and	NULL
-95	NULL
)	NULL
and	NULL
the	NULL
POS	NULL
site	NULL
(	NULL
located	NULL
between	NULL
bp	NULL
-193	NULL
and	NULL
-200	NULL
)	NULL
reduced	NULL
promoter	NULL
activity	NULL
by	NULL
65	NULL
and	NULL
39	NULL
%	NULL
relative	NULL
to	NULL
wild-type	NULL
activity	NULL
.	NULL

Lesser	NULL
reductions	NULL
in	NULL
promoter	NULL
activity	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
(	NULL
9	NULL
%	NULL
)	NULL
and	NULL
Egr-1/Spl	NULL
(	NULL
25	NULL
%	NULL
)	NULL
muta-tions	NULL
.	NULL

In	NULL
striking	NULL
contrast	NULL
,	NULL
mutagenesis	NULL
of	NULL
both	NULL
the	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
and	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
sites	NULL
resulted	NULL
in	NULL
an	NULL
83	NULL
%	NULL
decrease	NULL
in	NULL
CAT	NULL
activity	NULL
,	NULL
establishing	NULL
a	NULL
dominant	NULL
role	NULL
for	NULL
these	NULL
tandem	NULL
sites	NULL
in	NULL
overall	NULL
promoter	NULL
function	NULL
.	NULL

Transfections	NULL
of	NULL
these	NULL
constructs	NULL
were	NULL
also	NULL
performed	NULL
using	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
activated	NULL
with	NULL
PHA	NULL
and	NULL
IL-2	NULL
.	NULL

However	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
were	NULL
extremely	NULL
low	NULL
,	NULL
and	NULL
the	NULL
data	NULL
could	NULL
not	NULL
be	NULL
interpreted	NULL
.	NULL

The	NULL
5'-untranslated	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
IMPDH	NULL
type	NULL
II	NULL
genes	NULL
contain	NULL
identical	NULL
17-bp	NULL
repeats	NULL
that	NULL
are	NULL
represented	NULL
once	NULL
in	NULL
the	NULL
human	NULL
and	NULL
twice	NULL
in	NULL
the	NULL
mouse	NULL
gene	NULL
(	NULL
21	NULL
,	NULL
30	NULL
)	NULL
.	NULL

This	NULL
sequence	NULL
includes	NULL
an	NULL
AML1-binding	NULL
site	NULL
(	NULL
31	NULL
)	NULL
and	NULL
is	NULL
located	NULL
at	NULL
bp	NULL
-28	NULL
to	NULL
-44	NULL
relative	NULL
to	NULL
the	NULL
translation	NULL
initiation	NULL
site	NULL
in	NULL
the	NULL
human	NULL
gene	NULL
and	NULL
at	NULL
bp	NULL
-28	NULL
to	NULL
-44	NULL
and	NULL
-45	NULL
to	NULL
-61	NULL
in	NULL
the	NULL
mouse	NULL
gene	NULL
,	NULL
suggesting	NULL
an	NULL
important	NULL
functional	NULL
role	NULL
for	NULL
this	NULL
region	NULL
in	NULL
gene	NULL
expression	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
mutations	NULL
were	NULL
introduced	NULL
in	NULL
the	NULL
AML1-binding	NULL
site	NULL
.	NULL

Mutation	NULL
of	NULL
this	NULL
site	NULL
consistently	NULL
resulted	NULL
in	NULL
increased	NULL
promoter	NULL
activity	NULL
(	NULL
138	NULL
%	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
Nuclear	NULL
Protein	NULL
Binding	NULL
to	NULL
Individual	NULL
cis-Acting	NULL
Elements	NULL
by	NULL
EMSA-To	NULL
address	NULL
the	NULL
role	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
footprinted	NULL
elements	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
relevant	NULL
proteins	NULL
from	NULL
nuclear	NULL
extracts	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
POS	NULL
,	NULL
Egr-1/Sp1	NULL
,	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
,	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
AML1	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
using	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
resting	NULL
and	NULL
activated	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
PMA	NULL
.	NULL

Competition	NULL
experiments	NULL
with	NULL
wild-type	NULL
and	NULL
corresponding	NULL
mutant	NULL
oligonucleotides	NULL
confirmed	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
interactions	NULL
at	NULL
the	NULL
200	NULL
100	NULL
7	NULL
Relative	NULL
CAT	NULL
Activity	NULL
AML1	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
CRE	NULL
(	NULL
A+B	NULL
)	NULL
Egr-1/Sp1	NULL
Pos	NULL
o	NULL
8	NULL
tD	NULL
|-	NULL
<	NULL
O	NULL
a	NULL
Mutated	NULL
sites	NULL
pCATBasic461	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
mutagenesis	NULL
of	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
on	NULL
IMPDH	NULL
type	NULL
II	NULL
promoter	NULL
activity	NULL
.	NULL

Transcription	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
461-bp	NULL
promoter	NULL
fragment	NULL
were	NULL
subjected	NULL
to	NULL
site-directed	NULL
mutagenesis	NULL
using	NULL
the	NULL
oligonucleotides	NULL
outlined	NULL
in	NULL
Table	NULL
I	NULL
and	NULL
wild-type	NULL
and	NULL
mutant	NULL
constructs	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
pCATBasic461	NULL
(	NULL
100	NULL
%	NULL
)	NULL
and	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

sites	NULL
examined	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
illustrates	NULL
that	NULL
factors	NULL
present	NULL
in	NULL
resting	NULL
T	NULL
lymphocyte	NULL
nuclear	NULL
extract	NULL
bind	NULL
to	NULL
the	NULL
Egr-1/Spl	NULL
,	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
,	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
AML1	NULL
sites	NULL
as	NULL
well	NULL
as	NULL
the	NULL
POS	NULL
site	NULL
.	NULL

T	NULL
lymphocyte	NULL
nuclear	NULL
extract	NULL
obtained	NULL
at	NULL
3	NULL
and	NULL
6	NULL
h	NULL
after	NULL
activation	NULL
resulted	NULL
in	NULL
increased	NULL
binding	NULL
of	NULL
the	NULL
Eigr-1/Spl	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Binding	NULL
to	NULL
the	NULL
Egr-1/Spl	NULL
oligonucleotide	NULL
was	NULL
slightly	NULL
reduced	NULL
at	NULL
12	NULL
and	NULL
24	NULL
h	NULL
of	NULL
activation	NULL
,	NULL
whereas	NULL
binding	NULL
to	NULL
the	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
and	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
motifs	NULL
progressively	NULL
increased	NULL
up	NULL
to	NULL
24	NULL
h	NULL
of	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
consensus	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
element	NULL
(	NULL
TGACGTCA	NULL
)	NULL
was	NULL
found	NULL
to	NULL
be	NULL
consistently	NULL
stronger	NULL
than	NULL
binding	NULL
to	NULL
the	NULL
partial	NULL
consensus	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
element	NULL
(	NULL
TGACGAAA	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Nuclear	NULL
factor	NULL
binding	NULL
to	NULL
both	NULL
the	NULL
POS	NULL
and	NULL
the	NULL
AML	NULL
1	NULL
site	NULL
demonstrated	NULL
a	NULL
lower	NULL
mobility	NULL
shift	NULL
following	NULL
T	NULL
lymphocyte	NULL
activation	NULL
(	NULL
3	NULL
,	NULL
6	NULL
,	NULL
12	NULL
,	NULL
and	NULL
24	NULL
h	NULL
)	NULL
,	NULL
possibly	NULL
indicating	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
higher-order	NULL
complex	NULL
upon	NULL
T	NULL
lymphocyte	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

These	NULL
data	NULL
,	NULL
in	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
22920	NULL
PHA	NULL
+	NULL
IL2	NULL
PMA	NULL
a	NULL
E	NULL
g	NULL
T	NULL
lymphocyte	NULL
Judi	NULL
?	NULL

g	NULL
a	NULL
.	NULL

>	NULL
8	NULL
s	NULL
e	NULL
oc	NULL
§	NULL
{	NULL
oeoe	NULL
E	NULL
L	NULL
o	NULL
®	NULL
©	NULL
-	NULL
a	NULL
o	NULL
o	NULL
m	NULL
C	NULL
C	NULL
E	NULL
€	NULL
m	NULL
To	NULL
(	NULL
€~	NULL
in	NULL
b	NULL
buh	NULL
bop	NULL
boo	NULL
but	NULL
bs	NULL
'	NULL
Egr-1/Sp1	NULL
<	NULL
—	NULL
tnd	NULL
m	NULL
n	NULL
u	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
w	NULL
be	NULL
ua	NULL
ke	NULL
-	NULL
H8	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
AML1	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
POS	NULL
,	NULL
Egr-1/Spl	NULL
,	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
,	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
AML1	NULL
sites	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
resting	NULL
T	NULL
lymphocytes	NULL
and	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
with	NULL
1	NULL
ug/ml	NULL
PHA	NULL
and	NULL
10	NULL
units/ml	NULL
IL-2	NULL
for	NULL
3	NULL
,	NULL
6	NULL
,	NULL
12	NULL
,	NULL
and	NULL
24	NULL
h	NULL
and	NULL
control	NULL
and	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
,	NULL
3	NULL
h	NULL
)	NULL
-treated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

[	NULL
°H	NULL
]	NULL
Thymidine	NULL
incorporation	NULL
into	NULL
DNA	NULL
was	NULL
determined	NULL
for	NULL
the	NULL
T	NULL
lymphocytes	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
proliferative	NULL
activity	NULL
and	NULL
was	NULL
4-	NULL
,	NULL
2-	NULL
,	NULL
10-	NULL
,	NULL
and	NULL
9-fold	NULL
above	NULL
unstimulated	NULL
T	NULL
lymphocytes	NULL
for	NULL
the	NULL
3-	NULL
,	NULL
6-	NULL
,	NULL
12-	NULL
,	NULL
and	NULL
24-h	NULL
time	NULL
points	NULL
,	NULL
respectively	NULL
.	NULL

conjunction	NULL
with	NULL
the	NULL
in	NULL
vivo	NULL
footprinting	NULL
results	NULL
,	NULL
suggest	NULL
that	NULL
T	NULL
lymphocyte	NULL
activation	NULL
leads	NULL
to	NULL
increased	NULL
protein-DNA	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
that	NULL
does	NULL
not	NULL
per	NULL
se	NULL
coincide	NULL
with	NULL
additional	NULL
transcription	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
Egr-1/Spl	NULL
,	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
motifs	NULL
,	NULL
while	NULL
resulting	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
higher	NULL
order	NULL
complexes	NULL
at	NULL
the	NULL
POS	NULL
and	NULL
AML1	NULL
sites	NULL
.	NULL

Preliminary	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
on	NULL
the	NULL
POS	NULL
site	NULL
have	NULL
identified	NULL
three	NULL
proteins	NULL
in	NULL
the	NULL
range	NULL
of	NULL
35-45	NULL
kDa	NULL
in	NULL
both	NULL
the	NULL
lower	NULL
and	NULL
upper	NULL
protein-DNA	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
;	NULL
indicated	NULL
by	NULL
arrows	NULL
)	NULL
formed	NULL
with	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocyte	NULL
nuclear	NULL
extract	NULL
,	NULL
respectively	NULL
,	NULL
suggesting	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
multi-meric	NULL
protein	NULL
complex	NULL
at	NULL
this	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
factors	NULL
in	NULL
extracts	NULL
obtained	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
did	NULL
not	NULL
differ	NULL
from	NULL
that	NULL
obtained	NULL
from	NULL
resting	NULL
T	NULL
lymphocytes	NULL
,	NULL
whereas	NULL
extracts	NULL
obtained	NULL
from	NULL
PMA-stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
exhibited	NULL
binding	NULL
patterns	NULL
at	NULL
the	NULL
POS	NULL
,	NULL
Egr-1/Spl	NULL
,	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
,	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
AML	NULL
1	NULL
sites	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
PHA	NULL
and	NULL
IL-2-stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Only	NULL
at	NULL
the	NULL
overlapping	NULL
Egr-1/Spl	NULL
site	NULL
was	NULL
a	NULL
higher	NULL
mobility	NULL
complex	NULL
observed	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
PMA-stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
control	NULL
Jurkat	NULL
T	NULL
cell	NULL
and	NULL
resting	NULL
or	NULL
acti-	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IMPDH	NULL
Type	NULL
II	NULL
vated	NULL
T	NULL
lymphocyte	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
indicated	NULL
by	NULL
arrow	NULL
)	NULL
.	NULL

EMSA	NULL
of	NULL
the	NULL
Egr-1/Spl-binding	NULL
site	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
anti-Egr-1	NULL
and	NULL
anti-Spl	NULL
antibodies	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
control	NULL
and	NULL
PMA-treated	NULL
Jurkat	NULL
T	NULL
cells	NULL
revealed	NULL
that	NULL
the	NULL
low	NULL
mobility	NULL
complex	NULL
consists	NULL
of	NULL
the	NULL
Spl	NULL
transcription	NULL
factor	NULL
,	NULL
and	NULL
the	NULL
higher	NULL
mobility	NULL
complex	NULL
of	NULL
the	NULL
Egr-1	NULL
nuclear	NULL
factor	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

EMSA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
Egr-1	NULL
and	NULL
Spl	NULL
further	NULL
revealed	NULL
that	NULL
Egr-1	NULL
binding	NULL
is	NULL
absent	NULL
in	NULL
control	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
and	NULL
is	NULL
rapidly	NULL
induced	NULL
upon	NULL
PMA	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
a	NULL
similar	NULL
complex	NULL
in	NULL
activated	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
suggests	NULL
that	NULL
the	NULL
transcription	NULL
factor	NULL
Egr-1	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Further-more	NULL
,	NULL
although	NULL
the	NULL
Egr-1/Spl	NULL
site	NULL
(	NULL
CCGCCCCCGCC	NULL
)	NULL
exhibits	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
identity	NULL
to	NULL
a	NULL
consensus	NULL
AP2-binding	NULL
site	NULL
(	NULL
CCGCCCGCG	NULL
)	NULL
(	NULL
32	NULL
)	NULL
,	NULL
binding	NULL
of	NULL
AP2	NULL
was	NULL
not	NULL
detected	NULL
using	NULL
supershift	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
define	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
CRE	NULL
sites	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
with	NULL
the	NULL
consensus	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
control	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
and	NULL
an	NULL
ATF-1	NULL
antibody	NULL
(	NULL
sc-270X	NULL
)	NULL
that	NULL
recognizes	NULL
ATF-1-	NULL
,	NULL
CREB-1-	NULL
,	NULL
and	NULL
CREM-1	NULL
,	NULL
and	NULL
ATF-1	NULL
(	NULL
sc-241X	NULL
)	NULL
,	NULL
ATF-2	NULL
(	NULL
sc-187X	NULL
)	NULL
-	NULL
,	NULL
CREB-1	NULL
,	NULL
and	NULL
CREM-1	NULL
(	NULL
sc-440X	NULL
)	NULL
-specific	NULL
antibodies	NULL
.	NULL

The	NULL
consensus	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
site	NULL
was	NULL
used	NULL
in	NULL
preference	NULL
to	NULL
the	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
site	NULL
since	NULL
nuclear	NULL
factor	NULL
binding	NULL
was	NULL
consistently	NULL
found	NULL
to	NULL
be	NULL
more	NULL
pronounced	NULL
,	NULL
whereas	NULL
the	NULL
qualitative	NULL
results	NULL
obtained	NULL
with	NULL
the	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
and	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
sites	NULL
were	NULL
identical	NULL
using	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocyte	NULL
nuclear	NULL
extract	NULL
.	NULL

Indeed	NULL
,	NULL
competition	NULL
experiments	NULL
between	NULL
the	NULL
two	NULL
CRE	NULL
sites	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
control	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
revealed	NULL
that	NULL
each	NULL
site	NULL
completely	NULL
competes	NULL
with	NULL
the	NULL
other	NULL
for	NULL
protein	NULL
bind-ing	NULL
,	NULL
although	NULL
the	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
site	NULL
exhibits	NULL
a	NULL
10-fold	NULL
lower	NULL
affinity	NULL
than	NULL
does	NULL
the	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
antibody	NULL
sc-270X	NULL
to	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
resulted	NULL
in	NULL
a	NULL
supershift	NULL
of	NULL
the	NULL
lower	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
indicated	NULL
by	NULL
*	NULL
)	NULL
.	NULL

A	NULL
slight	NULL
supershift	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
ATF-1-specific	NULL
antibody	NULL
sc-241X	NULL
that	NULL
was	NULL
visible	NULL
upon	NULL
longer	NULL
exposure	NULL
(	NULL
loca-tion	NULL
indicated	NULL
)	NULL
.	NULL

Incubation	NULL
with	NULL
an	NULL
ATF-2-specific	NULL
antibody	NULL
(	NULL
sc-187X	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
partial	NULL
supershift	NULL
of	NULL
the	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
complex	NULL
to	NULL
an	NULL
upper	NULL
band	NULL
and	NULL
a	NULL
lower	NULL
band	NULL
that	NULL
comigrates	NULL
with	NULL
the	NULL
sc-270X	NULL
supershift	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
indicated	NULL
by	NULL
*	NULL
)	NULL
.	NULL

Antibodies	NULL
specific	NULL
for	NULL
CREB-1	NULL
(	NULL
sc-186X	NULL
)	NULL
and	NULL
CREM-1	NULL
(	NULL
sc-440X	NULL
)	NULL
did	NULL
not	NULL
result	NULL
in	NULL
a	NULL
supershift	NULL
of	NULL
the	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
mobility	NULL
shift	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
factors	NULL
are	NULL
not	NULL
represented	NULL
in	NULL
this	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
de	NULL
novo	NULL
cellular	NULL
synthesis	NULL
of	NULL
guanine	NULL
nucleotides	NULL
provides	NULL
necessary	NULL
substrates	NULL
for	NULL
both	NULL
DNA	NULL
and	NULL
RNA	NULL
synthesis	NULL
and	NULL
is	NULL
required	NULL
for	NULL
cell	NULL
proliferation	NULL
.	NULL

Depletion	NULL
of	NULL
guanine	NULL
nucleotides	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
inhibitors	NULL
of	NULL
IMPDH	NULL
enzymatic	NULL
activity	NULL
results	NULL
in	NULL
a	NULL
block	NULL
in	NULL
late	NULL
G	NULL
;	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
that	NULL
is	NULL
reversible	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
guanine	NULL
(	NULL
12	NULL
)	NULL
and	NULL
also	NULL
leads	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
differentiation	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
in	NULL
vitro	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
specific	NULL
molecular	NULL
trigger	NULL
for	NULL
G	NULL
;	NULL
arrest	NULL
is	NULL
not	NULL
known	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
phos-phorylation	NULL
of	NULL
the	NULL
Rb	NULL
protein	NULL
is	NULL
inhibited	NULL
under	NULL
these	NULL
condi-tions	NULL
,	NULL
``	NULL
establishing	NULL
the	NULL
importance	NULL
of	NULL
IMPDH	NULL
enzymatic	NULL
activity	NULL
for	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

Inhibitors	NULL
of	NULL
IMPDH	NULL
are	NULL
also	NULL
known	NULL
to	NULL
be	NULL
very	NULL
effective	NULL
immunosuppressive	NULL
agents	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
,	NULL
and	NULL
previous	NULL
studies	NULL
have	NULL
documented	NULL
the	NULL
requirement	NULL
for	NULL
a	NULL
10-15-fold	NULL
increase	NULL
in	NULL
IMPDH	NULL
activity	NULL
for	NULL
normal	NULL
T	NULL
lymphocyte	NULL
activation	NULL
(	NULL
14	NULL
,	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
examined	NULL
to	NULL
date	NULL
,	NULL
the	NULL
ability	NULL
to	NULL
stimulate	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
from	NULL
a	NULL
resting	NULL
to	NULL
proliferating	NULL
state	NULL
and	NULL
the	NULL
importance	NULL
of	NULL
IMPDH	NULL
activity	NULL
for	NULL
*	NULL
J.	NULL
Laliberté	NULL
and	NULL
B.	NULL
S.	NULL
Mitchell	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IMPDH	NULL
Type	NULL
II	NULL
A	NULL
CONTROL	NULL
PMA	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Characterization	NULL
of	NULL
Egr-1	NULL
and	NULL
Spl	NULL
binding	NULL
to	NULL
the	NULL
overlapping	NULL
consensus	NULL
Egr-1/Spl	NULL
sites	NULL
.	NULL

EMSA	NULL
and	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
control	NULL
and	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
,	NULL
3	NULL
h	NULL
)	NULL
-treated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
transcription	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
wild-type	NULL
IMPDH	NULL
type	NULL
II	NULL
oligonucleotide	NULL
(	NULL
GC-CAGCTCCGCCCCCGCCGCAGCGAG	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
anti-Spl	NULL
and	NULL
t6	NULL
anti-Egr-1	NULL
antibodies	NULL
.	NULL

B	NULL
,	NULL
transcription	NULL
u	NULL
factor	NULL
binding	NULL
to	NULL
consensus	NULL
Spl	NULL
(	NULL
CTCGC-	NULL
CCCGCCCCGATCGAAT	NULL
)	NULL
and	NULL
Egr-1	NULL
IMPDH	NULL
II	NULL
:	NULL
Egr-1/Sp1	NULL
site	NULL
Jurkat	NULL
a-Sp1	NULL
o-Egr-1	NULL
Jurkat	NULL
«	NULL
-Sp1	NULL
a-Egr-1	NULL
«	NULL
*	NULL
ap	NULL
»	NULL
TCC	NULL
)	NULL
sites	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
anti-Spl	NULL
and	NULL
anti-Egr-1	NULL
antibodies	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
EMSA	NULL
complexes	NULL
for	NULL
A	NULL
and	NULL
B	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
side	NULL
of	NULL
B.	NULL
a-ATF-1/CREB-1/CREM-1	NULL
(	NULL
s0-270	NULL
%	NULL
)	NULL
a	NULL
=	NULL
§	NULL
8	NULL
<	NULL
<	NULL
$	NULL
9	NULL
oC	NULL
2	NULL
%	NULL
©	NULL
os	NULL
To	NULL
}	NULL
1	NULL
%	NULL
g	NULL
&	NULL
d	NULL
d	NULL
&	NULL
&	NULL
&	NULL
2	NULL
+	NULL
«	NULL
of	NULL
d	NULL
3	NULL
C	NULL
EOE	NULL
E	NULL
@	NULL
El	NULL
401	NULL
9	NULL
9	NULL
i	NULL
a	NULL
s	NULL
s	NULL
s	NULL
8	NULL
--	NULL
-	NULL
ATF-2	NULL
supershift	NULL
--	NULL
-	NULL
ATF-1	NULL
supershift	NULL
b	NULL
4	NULL
A4	NULL
-f-	NULL
*	NULL
Ms	NULL
oe	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
consensus	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
element	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
antibody	NULL
ATF-1	NULL
(	NULL
sc-270X	NULL
;	NULL
recognizes	NULL
ATF-1	NULL
,	NULL
CREB-1	NULL
,	NULL
and	NULL
CREM-1	NULL
)	NULL
and	NULL
specific	NULL
antibodies	NULL
for	NULL
ATF-2	NULL
(	NULL
sc-187X	NULL
)	NULL
,	NULL
ATF-1	NULL
(	NULL
sc-241X	NULL
)	NULL
,	NULL
CREB-1	NULL
(	NULL
sc-186X	NULL
)	NULL
,	NULL
and	NULL
CREM-1	NULL
(	NULL
sc-440X	NULL
)	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
site	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
EMSA	NULL
supershift	NULL
complexes	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
side	NULL
of	NULL
the	NULL
panel	NULL
.	NULL

the	NULL
immune	NULL
response	NULL
prompted	NULL
us	NULL
to	NULL
use	NULL
these	NULL
non-trans-formed	NULL
cells	NULL
to	NULL
examine	NULL
the	NULL
regulation	NULL
of	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
growth	NULL
stimuli	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
objectives	NULL
of	NULL
the	NULL
present	NULL
study	NULL
were	NULL
first	NULL
to	NULL
confirm	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
IMPDH	NULL
type	NULL
II	NULL
expression	NULL
was	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
and	NULL
second	NULL
to	NULL
define	NULL
the	NULL
specific	NULL
components	NULL
involved	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

The	NULL
finding	NULL
of	NULL
identical	NULL
IMPDH	NULL
type	NULL
II	NULL
mRNA	NULL
stabilities	NULL
at	NULL
increasing	NULL
time	NULL
intervals	NULL
following	NULL
T	NULL
lymphocyte	NULL
activation	NULL
complements	NULL
our	NULL
previous	NULL
data	NULL
demonstrating	NULL
a	NULL
transcriptional	NULL
response	NULL
of	NULL
the	NULL
transfected	NULL
IMPDH	NULL
type	NULL
II	NULL
promoter	NULL
region	NULL
to	NULL
cellular	NULL
activation	NULL
with	NULL
phorbol	NULL
ester	NULL
and	NULL
ionomycin	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Chromatin	NULL
structure	NULL
analysis	NULL
identified	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
both	NULL
5°	NULL
and	NULL
3	NULL
'	NULL
to	NULL
the	NULL
gene	NULL
that	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
more	NULL
detailed	NULL
sequence	NULL
analysis	NULL
and	NULL
the	NULL
demonstration	NULL
of	NULL
two	NULL
adjacent	NULL
genes	NULL
have	NULL
made	NULL
interpretation	NULL
of	NULL
these	NULL
data	NULL
more	NULL
22921	NULL
B	NULL
CONTROL	NULL
PMA	NULL
CONTROL	NULL
PMA	NULL
$	NULL
f	NULL
fG	NULL
{	NULL
fff	NULL
G	NULL
1	NULL
8	NULL
4	NULL
8	NULL
4	NULL
#	NULL
4	NULL
@	NULL
#	NULL
*	NULL
gum	NULL
.	NULL

--	NULL
-	NULL
Egr-1	NULL
supershift	NULL
il	NULL
[	NULL
--	NULL
-	NULL
Spi	NULL
supershift	NULL
&	NULL
..	NULL
pull	NULL
[	NULL
-al	NULL
--	NULL
Egr-1	NULL
consensus	NULL
Sp1	NULL
consensus	NULL
Egr-1	NULL
difficult	NULL
.	NULL

The	NULL
presumption	NULL
that	NULL
the	NULL
two	NULL
3'-hypersensitive	NULL
sites	NULL
are	NULL
associated	NULL
with	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
relatively	NULL
small	NULL
downstream	NULL
gene	NULL
is	NULL
a	NULL
reasonable	NULL
one	NULL
,	NULL
although	NULL
experimental	NULL
data	NULL
are	NULL
needed	NULL
to	NULL
support	NULL
this	NULL
hypothesis	NULL
.	NULL

The	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
(	NULL
bp	NULL
-286	NULL
to	NULL
+46	NULL
)	NULL
was	NULL
independently	NULL
isolated	NULL
and	NULL
found	NULL
to	NULL
contain	NULL
a	NULL
CpG	NULL
island	NULL
in	NULL
a	NULL
study	NULL
in	NULL
which	NULL
the	NULL
rat	NULL
chromosomal	NULL
protein	NULL
MeCP2	NULL
containing	NULL
a	NULL
methyl-CpG	NULL
binding	NULL
domain	NULL
was	NULL
used	NULL
to	NULL
isolate	NULL
such	NULL
sequences	NULL
(	NULL
GenBank	NULL
Z66268	NULL
)	NULL
(	NULL
35	NULL
)	NULL
.	NULL

These	NULL
data	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
our	NULL
prior	NULL
sequence	NULL
analysis	NULL
and	NULL
transient	NULL
transfection	NULL
experiments	NULL
,	NULL
have	NULL
confirmed	NULL
the	NULL
regulatory	NULL
potential	NULL
of	NULL
this	NULL
region	NULL
and	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
specific	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
including	NULL
an	NULL
Egr-1	NULL
site	NULL
,	NULL
that	NULL
were	NULL
candidate	NULL
mediators	NULL
of	NULL
growth-related	NULL
gene	NULL
expression	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
on	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
several	NULL
cell	NULL
lines	NULL
using	NULL
in	NULL
vivo	NULL
footprinting	NULL
have	NULL
identified	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
that	NULL
are	NULL
occupied	NULL
both	NULL
constitutively	NULL
and	NULL
inducibly	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Our	NULL
in	NULL
vivo	NULL
footprinting	NULL
studies	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
promoter	NULL
have	NULL
defined	NULL
five	NULL
regions	NULL
of	NULL
extensive	NULL
protein-DNA	NULL
contacts	NULL
that	NULL
colocalize	NULL
with	NULL
the	NULL
following	NULL
transcription	NULL
factor	NULL
binding	NULL
motifs	NULL
:	NULL
tandem	NULL
CRE	NULL
sites	NULL
,	NULL
a	NULL
Spl	NULL
site	NULL
,	NULL
an	NULL
overlapping	NULL
Egr-1/Spl	NULL
site	NULL
,	NULL
and	NULL
a	NULL
previously	NULL
uncharacterized	NULL
,	NULL
extensively	NULL
protected	NULL
POS	NULL
.	NULL

The	NULL
pattern	NULL
representative	NULL
of	NULL
proteins	NULL
binding	NULL
to	NULL
these	NULL
regions	NULL
showed	NULL
minor	NULL
modifications	NULL
at	NULL
the	NULL
AML	NULL
1	NULL
,	NULL
Egr-1/Sp1	NULL
,	NULL
and	NULL
POS	NULL
sites	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
transcription	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
may	NULL
be	NULL
related	NULL
to	NULL
modifications	NULL
of	NULL
pre-bound	NULL
transcription	NULL
factors	NULL
and/or	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
additional	NULL
nuclear	NULL
regulatory	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
to	NULL
pre-bound	NULL
proteins	NULL
at	NULL
these	NULL
sites	NULL
rather	NULL
than	NULL
to	NULL
additional	NULL
protein-DNA	NULL
interactions	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
the	NULL
Egr-1/8p1	NULL
and	NULL
POS	NULL
sites	NULL
are	NULL
further	NULL
established	NULL
by	NULL
deletion	NULL
experiments	NULL
,	NULL
where	NULL
removal	NULL
of	NULL
a	NULL
56-bp	NULL
region	NULL
containing	NULL
these	NULL
sites	NULL
reduced	NULL
promoter	NULL
activity	NULL
by	NULL
more	NULL
than	NULL
70	NULL
%	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
the	NULL
site-directed	NULL
mutagenesis	NULL
data	NULL
.	NULL

The	NULL
POS	NULL
site	NULL
(	NULL
CGCATGCG	NULL
)	NULL
has	NULL
not	NULL
been	NULL
previously	NULL
identified	NULL
as	NULL
important	NULL
in	NULL
nuclear	NULL
protein	NULL
binding	NULL
assays	NULL
according	NULL
to	NULL
analysis	NULL
of	NULL
defined	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
as	NULL
contained	NULL
in	NULL
the	NULL
Genetics	NULL
Computer	NULL
Group	NULL
data	NULL
base	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
the	NULL
sequence	NULL
demonstrated	NULL
a	NULL
shift	NULL
in	NULL
both	NULL
resting	NULL
T	NULL
lymphocytes	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
higher	NULL
order	NULL
complex	NULL
upon	NULL
PHA	NULL
and	NULL
IL-2	NULL
stimulation	NULL
and	NULL
PMA	NULL
treat-ment	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
this	NULL
sequence	NULL
clearly	NULL
binds	NULL
nuclear	NULL
protein	NULL
in	NULL
resting	NULL
T	NULL
lymphocytes	NULL
and	NULL
further	NULL
suggests	NULL
that	NULL
non-DNA	NULL
binding	NULL
accessory	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
may	NULL
bind	NULL
following	NULL
T	NULL
lymphocyte	NULL
activation	NULL
and	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
PMA	NULL
treatment	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

UV	NULL
cross-linking	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
22922	NULL
experiments	NULL
at	NULL
this	NULL
site	NULL
have	NULL
consistently	NULL
identified	NULL
three	NULL
distinct	NULL
proteins	NULL
in	NULL
the	NULL
range	NULL
of	NULL
35-45	NULL
kDa	NULL
in	NULL
the	NULL
high	NULL
mobility	NULL
complex	NULL
that	NULL
predominates	NULL
in	NULL
resting	NULL
T	NULL
lymphocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

No	NULL
additional	NULL
proteins	NULL
were	NULL
identified	NULL
in	NULL
the	NULL
low	NULL
mobility	NULL
complex	NULL
observed	NULL
with	NULL
stimulated	NULL
T	NULL
lymphocyte	NULL
nuclear	NULL
extract	NULL
,	NULL
although	NULL
a	NULL
slight	NULL
extension	NULL
of	NULL
the	NULL
POS	NULL
footprint	NULL
upon	NULL
PHA	NULL
and	NULL
IL-2	NULL
stimulation	NULL
suggests	NULL
that	NULL
such	NULL
binding	NULL
may	NULL
occur	NULL
in	NULL
vivo	NULL
.	NULL

Despite	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
sequence	NULL
surrounding	NULL
and	NULL
including	NULL
the	NULL
POS	NULL
site	NULL
(	NULL
ATACGCATGCG	NULL
)	NULL
exhibits	NULL
some	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
(	NULL
ATTTGCAT	NULL
)	NULL
,	NULL
the	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
proteins	NULL
are	NULL
of	NULL
significantly	NULL
higher	NULL
molecular	NULL
mass	NULL
(	NULL
90	NULL
and	NULL
60	NULL
kDa	NULL
,	NULL
respec-tively	NULL
)	NULL
than	NULL
those	NULL
observed	NULL
in	NULL
our	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

The	NULL
further	NULL
characterization	NULL
of	NULL
the	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
POS	NULL
site	NULL
may	NULL
lead	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
that	NULL
will	NULL
be	NULL
highly	NULL
relevant	NULL
to	NULL
our	NULL
overall	NULL
understanding	NULL
of	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
overlapping	NULL
Egr-1/Spl-binding	NULL
site	NULL
binds	NULL
Spl	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
and	NULL
inducibly	NULL
binds	NULL
Egr-1	NULL
after	NULL
phorbol	NULL
ester	NULL
treatment	NULL
.	NULL

However	NULL
,	NULL
no	NULL
equivalent	NULL
shift	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
was	NULL
found	NULL
in	NULL
PHA	NULL
and	NULL
IL-2-stimulated	NULL
T	NULL
lymphocytes	NULL
,	NULL
arguing	NULL
that	NULL
Egr-1	NULL
does	NULL
not	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
expression	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

Although	NULL
Egr-1	NULL
is	NULL
expressed	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
and	NULL
can	NULL
bind	NULL
to	NULL
its	NULL
consensus	NULL
site	NULL
in	NULL
EMSA	NULL
assays	NULL
,	NULL
the	NULL
in	NULL
vivo	NULL
footprinting	NULL
results	NULL
do	NULL
not	NULL
reveal	NULL
a	NULL
distinguishable	NULL
difference	NULL
in	NULL
the	NULL
contact	NULL
sites	NULL
at	NULL
the	NULL
overlapping	NULL
Egr-l1/Spl	NULL
site	NULL
between	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
their	NULL
T	NULL
lymphocyte	NULL
counterparts	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
Egr-1	NULL
is	NULL
unable	NULL
to	NULL
compete	NULL
for	NULL
Spl	NULL
binding	NULL
at	NULL
this	NULL
site	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

Although	NULL
Egr-1	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
40	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
transiently	NULL
in	NULL
rat	NULL
T	NULL
lymphocytes	NULL
following	NULL
IL-2	NULL
or	NULL
concanavalin	NULL
A	NULL
treatment	NULL
(	NULL
41	NULL
)	NULL
,	NULL
and	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
several	NULL
genes	NULL
including	NULL
IL-2	NULL
and	NULL
thymidine	NULL
kinase	NULL
(	NULL
40	NULL
,	NULL
42	NULL
)	NULL
,	NULL
the	NULL
recent	NULL
demonstration	NULL
that	NULL
Egr-l-deficient	NULL
mice	NULL
,	NULL
although	NULL
deficient	NULL
in	NULL
luteinizing	NULL
hormone	NULL
,	NULL
have	NULL
no	NULL
major	NULL
developmental	NULL
defects	NULL
(	NULL
43	NULL
)	NULL
suggests	NULL
that	NULL
Egr-1	NULL
is	NULL
not	NULL
important	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
growth-related	NULL
genes	NULL
such	NULL
as	NULL
IMPDH	NULL
type	NULL
II	NULL
.	NULL

Based	NULL
on	NULL
our	NULL
findings	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
Spl	NULL
and	NULL
not	NULL
Egr-1	NULL
binding	NULL
at	NULL
the	NULL
Egr-1/Spl	NULL
site	NULL
contributes	NULL
to	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
expression	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
proximal	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
motif	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
profound	NULL
impairment	NULL
of	NULL
promoter	NULL
activity	NULL
,	NULL
whereas	NULL
loss	NULL
of	NULL
the	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
site	NULL
with	NULL
identical	NULL
protein	NULL
binding	NULL
properties	NULL
on	NULL
EMSA	NULL
had	NULL
little	NULL
effect	NULL
.	NULL

However	NULL
,	NULL
simultaneous	NULL
mutation	NULL
of	NULL
the	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
and	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
sites	NULL
resulted	NULL
in	NULL
an	NULL
83	NULL
%	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
,	NULL
demonstrating	NULL
an	NULL
important	NULL
role	NULL
of	NULL
the	NULL
tandem	NULL
elements	NULL
for	NULL
overall	NULL
promoter	NULL
function	NULL
.	NULL

This	NULL
functional	NULL
importance	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
CRE	NULL
(	NULL
A	NULL
)	NULL
and	NULL
CRE	NULL
(	NULL
B	NULL
)	NULL
sites	NULL
are	NULL
conserved	NULL
at	NULL
the	NULL
same	NULL
location	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
in	NULL
the	NULL
mouse	NULL
IMPDH	NULL
type	NULL
II	NULL
pro-moter	NULL
.	NULL
``	NULL

Supershift	NULL
analysis	NULL
of	NULL
both	NULL
CRE	NULL
motifs	NULL
identified	NULL
ATF-2	NULL
as	NULL
the	NULL
predominant	NULL
protein	NULL
that	NULL
binds	NULL
from	NULL
both	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocyte	NULL
and	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extracts	NULL
,	NULL
with	NULL
evidence	NULL
that	NULL
ATF-1	NULL
and/or	NULL
another	NULL
unidentified	NULL
member	NULL
of	NULL
the	NULL
ATF/CRE	NULL
family	NULL
may	NULL
also	NULL
bind	NULL
.	NULL

Although	NULL
,	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
demonstrate	NULL
a	NULL
quantitative	NULL
increase	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
ATF-2	NULL
(	NULL
70	NULL
kDa	NULL
)	NULL
after	NULL
T	NULL
lymphocyte	NULL
activation	NULL
using	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
ATF-2	NULL
is	NULL
the	NULL
most	NULL
plausible	NULL
candidate	NULL
for	NULL
mediating	NULL
both	NULL
the	NULL
basal	NULL
and	NULL
inducible	NULL
transac-tivation	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
.	NULL

ATF-2	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
in	NULL
stimulated	NULL
T	NULL
cells	NULL
(	NULL
44	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
transacti-	NULL
°	NULL
A.	NULL
P.	NULL
A.	NULL
Stegmann	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

Transcriptional	NULL
Regulation	NULL
of	NULL
IMPDH	NULL
Type	NULL
II	NULL
vation	NULL
by	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
Tax	NULL
(	NULL
45	NULL
)	NULL
and	NULL
ade-novirus	NULL
ElA	NULL
proteins	NULL
(	NULL
46	NULL
,	NULL
47	NULL
)	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
ATF-2	NULL
.	NULL

Finally	NULL
,	NULL
as	NULL
a	NULL
target	NULL
of	NULL
the	NULL
JNK	NULL
signal	NULL
transduction	NULL
pathway	NULL
(	NULL
48	NULL
)	NULL
,	NULL
this	NULL
transcription	NULL
factor	NULL
may	NULL
be	NULL
integrally	NULL
involved	NULL
in	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
important	NULL
for	NULL
cell	NULL
proliferation	NULL
and	NULL
transformation	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
data	NULL
provide	NULL
evidence	NULL
that	NULL
ATF-2	NULL
,	NULL
Spl	NULL
,	NULL
and	NULL
a	NULL
POS-binding	NULL
protein	NULL
are	NULL
important	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
expression	NULL
in	NULL
vivo	NULL
in	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
and	NULL
,	NULL
by	NULL
extension	NULL
,	NULL
in	NULL
the	NULL
provision	NULL
of	NULL
guanine	NULL
nucleotides	NULL
required	NULL
for	NULL
cell	NULL
growth	NULL
.	NULL

The	NULL
transcriptional	NULL
up-regulation	NULL
of	NULL
the	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
require	NULL
major	NULL
additional	NULL
protein	NULL
binding	NULL
directly	NULL
to	NULL
the	NULL
core	NULL
promoter	NULL
region	NULL
but	NULL
may	NULL
well	NULL
involve	NULL
events	NULL
such	NULL
as	NULL
secondary	NULL
protein-protein	NULL
interactions	NULL
and/or	NULL
post-translational	NULL
modifications	NULL
of	NULL
pre-bound	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
the	NULL
novel	NULL
POS	NULL
should	NULL
lead	NULL
to	NULL
its	NULL
recognition	NULL
in	NULL
the	NULL
sequences	NULL
of	NULL
other	NULL
promoters	NULL
,	NULL
and	NULL
further	NULL
delineation	NULL
of	NULL
the	NULL
nature	NULL
and	NULL
availability	NULL
of	NULL
proteins	NULL
binding	NULL
to	NULL
it	NULL
will	NULL
enhance	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
IMPDH	NULL
type	NULL
II	NULL
gene	NULL
expression	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Carr	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Papp	NULL
,	NULL
E.	NULL
,	NULL
Wu	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
Natsumeda	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
27286-27290	NULL
.	NULL

Collart	NULL
,	NULL
F.	NULL
R.	NULL
,	NULL
and	NULL
Huberman	NULL
,	NULL
E.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
15769-15772	NULL
.	NULL

Glesne	NULL
,	NULL
D.	NULL
,	NULL
Collart	NULL
,	NULL
F.	NULL
,	NULL
Varkony	NULL
,	NULL
T.	NULL
,	NULL
Drabkin	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Huberman	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Genomics	NULL
16	NULL
,	NULL
274-277	NULL
4	NULL
.	NULL

Gu	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Kaiser-Rogers	NULL
,	NULL
K.	NULL
,	NULL
Rao	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Mitchell	NULL
,	NULL
B.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Genomics	NULL
24	NULL
,	NULL
179-181	NULL
5	NULL
.	NULL

Natsumeda	NULL
,	NULL
Y.	NULL
,	NULL
Ohno	NULL
,	NULL
S.	NULL
,	NULL
Kawasaki	NULL
,	NULL
H.	NULL
,	NULL
Konno	NULL
,	NULL
Y.	NULL
,	NULL
Weber	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Suzuki	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
5292-5295	NULL
.	NULL

Jackson	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
Weber	NULL
,	NULL
G.	NULL
(	NULL
1975	NULL
)	NULL
Nature	NULL
256	NULL
,	NULL
881-333	NULL
.	NULL

Weber	NULL
,	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

48	NULL
,	NULL
8466-3492	NULL
.	NULL

Collart	NULL
,	NULL
F.	NULL
R.	NULL
,	NULL
Chubb	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Mirkin	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
and	NULL
Huberman	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

52	NULL
,	NULL
5826-5828	NULL
9	NULL
.	NULL

Konno	NULL
,	NULL
Y.	NULL
,	NULL
Natsumeda	NULL
,	NULL
Y.	NULL
,	NULL
Nagai	NULL
,	NULL
M.	NULL
,	NULL
Yamaiji	NULL
,	NULL
Y.	NULL
,	NULL
Ohno	NULL
,	NULL
S.	NULL
,	NULL
Suzuki	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Weber	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
506-509	NULL
10	NULL
.	NULL

Nagai	NULL
,	NULL
M.	NULL
,	NULL
Natsumeda	NULL
,	NULL
Y.	NULL
,	NULL
Konno	NULL
,	NULL
Y.	NULL
,	NULL
Hoffman	NULL
,	NULL
R.	NULL
,	NULL
Irino	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Weber	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

51	NULL
,	NULL
3886-3890	NULL
11	NULL
.	NULL

Nagai	NULL
,	NULL
M.	NULL
,	NULL
Natsumeda	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Weber	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

52	NULL
,	NULL
258-261	NULL
12	NULL
.	NULL

Dayton	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Turka	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Mitchell	NULL
,	NULL
B.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

41	NULL
,	NULL
671-676	NULL
13	NULL
.	NULL

Tricot	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Jayaram	NULL
,	NULL
H.	NULL
N.	NULL
,	NULL
Lapis	NULL
,	NULL
E.	NULL
,	NULL
Natsumeda	NULL
,	NULL
Y.	NULL
,	NULL
Nichols	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Kneebone	NULL
,	NULL
P.	NULL
,	NULL
Heerema	NULL
,	NULL
N.	NULL
,	NULL
Weber	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Hoffman	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

49	NULL
,	NULL
3696-3701	NULL
14	NULL
.	NULL

Turka	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Dayton	NULL
,	NULL
J.	NULL
,	NULL
Sinclair	NULL
,	NULL
G.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Mitchell	NULL
,	NULL
B.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87	NULL
,	NULL
940-948	NULL
15	NULL
.	NULL

Kiguchi	NULL
,	NULL
K.	NULL
,	NULL
Collart	NULL
,	NULL
F.	NULL
R.	NULL
,	NULL
Henning-Chubb	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Huberman	NULL
,	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
1	NULL
,	NULL
259-270	NULL
16	NULL
.	NULL

Kiguchi	NULL
,	NULL
K.	NULL
,	NULL
Collart	NULL
,	NULL
F.	NULL
R.	NULL
,	NULL
Henning-Chubb	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Huberman	NULL
,	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

187	NULL
,	NULL
47-58	NULL
17	NULL
.	NULL

Olah	NULL
,	NULL
E.	NULL
,	NULL
Natsumeda	NULL
,	NULL
Y.	NULL
,	NULL
Ikegami	NULL
,	NULL
T.	NULL
,	NULL
Kote	NULL
,	NULL
Z.	NULL
,	NULL
Horanyi	NULL
,	NULL
M.	NULL
,	NULL
Szelenyi	NULL
,	NULL
J.	NULL
,	NULL
Paulik	NULL
,	NULL
E.	NULL
,	NULL
Kremmer	NULL
,	NULL
T.	NULL
,	NULL
Hollan	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Sugar	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Weber	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
6533-6537	NULL
18	NULL
.	NULL

Sokoloski	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Blair	NULL
,	NULL
O.	NULL
C.	NULL
,	NULL
and	NULL
Sartorelli	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

46	NULL
,	NULL
2314-2319	NULL
19	NULL
.	NULL

Danovitch	NULL
,	NULL
G.	NULL
,	NULL
Deierhoi	NULL
,	NULL
M.	NULL
,	NULL
Ferguson	NULL
,	NULL
R.	NULL
,	NULL
Linna	NULL
,	NULL
J.	NULL
,	NULL
Monroe	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Tomlanovich	NULL
,	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Transplantation	NULL
61	NULL
,	NULL
722-729	NULL
20	NULL
.	NULL

Sollinger	NULL
,	NULL
H.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Transplantation	NULL
60	NULL
,	NULL
225-282	NULL
21	NULL
.	NULL

Zimmermann	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Spychala	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Mitchell	NULL
,	NULL
B.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
6808-6814	NULL
22	NULL
.	NULL

Wu	NULL
,	NULL
C.	NULL
(	NULL
1980	NULL
)	NULL
Nature	NULL
286	NULL
,	NULL
854-860	NULL
28	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
Wiskocil	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Stobo	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

188	NULL
,	NULL
123-128	NULL
24	NULL
.	NULL

Pfeifer	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Tanguay	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Steigerwald	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
and	NULL
Riggs	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1277-1287	NULL
25	NULL
.	NULL

Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Wold	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
780-786	NULL
26	NULL
.	NULL

Wright	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
Ting	NULL
,	NULL
J.	NULL
P.-Y	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
7601-7605	NULL
27	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
28	NULL
.	NULL

Blake	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Jambou	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Swick	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Kahn	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Azizkhan	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
6632-6641	NULL
29	NULL
.	NULL

Jones	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
BioTechniques	NULL
10	NULL
,	NULL
62-66	NULL
30	NULL
.	NULL

Tiedeman	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

97	NULL
,	NULL
289-298	NULL
31	NULL
.	NULL

Satake	NULL
,	NULL
M.	NULL
,	NULL
Ibaraki	NULL
,	NULL
T.	NULL
,	NULL
Yamaguchi	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
3669-3677	NULL
32	NULL
.	NULL

Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
251-260	NULL
33	NULL
.	NULL

Dayton	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Lindsten	NULL
,	NULL
T.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Mitchell	NULL
,	NULL
B.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
984-991	NULL
34	NULL
.	NULL

Fairbanks	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Bofill	NULL
,	NULL
M.	NULL
,	NULL
Ruckemann	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Simmonds	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
29682-29689	NULL
35	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Charlton	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Nan	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Bird	NULL
,	NULL
A.	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Nat	NULL
.	NULL

Genet	NULL
.	NULL

6	NULL
,	NULL
236-244	NULL
to	NULL
bo	NULL
g	NULL
=1	NULL
®	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Transcriptional	NULL
Regulation	NULL
of	NULL
IMPDH	NULL
Type	NULL
II	NULL
Brunvand	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Krumm	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
4824-4829	NULL
Garrity	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
D.	NULL
,	NULL
Rothenberg	NULL
,	NULL
E.	NULL
V.	NULL
,	NULL
and	NULL
Wold	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
2159-2169	NULL
Fletcher	NULL
,	NULL
C.	NULL
,	NULL
Heintz	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
7783-781	NULL
Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
Heguy	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
788-793	NULL
Skerka	NULL
,	NULL
C.	NULL
,	NULL
Decker	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
and	NULL
Zipfel	NULL
,	NULL
P.	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
22500-22506	NULL
Perez-Castillo	NULL
,	NULL
A.	NULL
,	NULL
Pipaon	NULL
,	NULL
C.	NULL
,	NULL
Garcia	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Alemany	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
19445-19450	NULL
Molnar	NULL
,	NULL
G.	NULL
,	NULL
Crozat	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Pardee	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5242-5248	NULL
43	NULL
44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

22923	NULL
.	NULL

Lee	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Sadovsky	NULL
,	NULL
Y.	NULL
,	NULL
Swimnoff	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Polish	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Goda	NULL
,	NULL
P.	NULL
,	NULL
Gavrilina	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Milbrandt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Science	NULL
278	NULL
,	NULL
1219-1221	NULL
Tsai	NULL
,	NULL
E.	NULL
Y.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Pesavento	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
459-467	NULL
Franklin	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Kubik	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Uittenbogaard	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Brauweiler	NULL
,	NULL
A.	NULL
,	NULL
Utaisincharoen	NULL
,	NULL
P.	NULL
,	NULL
Matthews	NULL
,	NULL
M.-A	NULL
.	NULL

H.	NULL
,	NULL
Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Hoeffler	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
21225-21231	NULL
Liu	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
1217-1224	NULL
Liu	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
868	NULL
,	NULL
520-525	NULL
Gupta	NULL
,	NULL
S.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
Dérijard	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
389-393	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Regulation	NULL
of	NULL
Inosine-5'-monophosphate	NULL
Dehydrogenase	NULL
Type	NULL
II	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
T	NULL
Cells	NULL
:	NULL
ROLE	NULL
FOR	NULL
A	NULL
NOVEL	NULL
5	NULL
'	NULL
PALINDROMIC	NULL
OCTAMER	NULL
SEQUENCE	NULL
Albert	NULL
G.	NULL
Zimmermann	NULL
,	NULL
Kenneth	NULL
L.	NULL
Wright	NULL
,	NULL
Jenuy	NULL
P.-Y	NULL
.	NULL

Ting	NULL
and	NULL
Beverly	NULL
S.	NULL
Mitchell	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:22913-22923.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.36.22913	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/36/22913	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
48	NULL
references	NULL
,	NULL
30	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
3.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

